Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Regulation of Microtubule Cytoskeleton WP2038,2.580162885928895e-06,5.571488764044944,71.69201211668373,"['GSK3B', 'ROCK1', 'PTEN', 'PRKCA', 'TIAM1', 'DIAPH1', 'PAK1', 'CLIP1', 'APC', 'TAOK1', 'GNAQ', 'ABL1', 'CLASP1', 'MARK2', 'MARK1']",0.0012229972079302962,0,0,15
2,TGF-beta Signaling Pathway WP366,1.1013546141873551e-05,2.8926687506105306,33.023818906087115,"['ROCK1', 'ZFYVE9', 'HDAC1', 'CUL1', 'PRKAR2A', 'EP300', 'MAPK1', 'BTRC', 'MAP3K7', 'RNF111', 'PDK1', 'MEF2A', 'MAP2K3', 'SMAD2', 'MAP2K4', 'MEF2C', 'CREBBP', 'SMURF2', 'NUP153', 'PIAS2', 'PTK2', 'PIAS1', 'ZEB2', 'ITCH', 'ZFYVE16', 'RBL1', 'SOS1']",0.0026102104356240316,0,0,27
3,Mesodermal commitment pathway WP2857,2.947378524515377e-05,2.8387725532135093,29.61410174794581,"['MACF1', 'SETD2', 'BMPR2', 'NCAPG2', 'ACACA', 'MBTD1', 'EPB41L5', 'TRIM28', 'JAK2', 'JARID2', 'SMAD2', 'EMSY', 'PIAS1', 'EXT1', 'LATS1', 'EXT2', 'CCDC88A', 'TOX3', 'DDAH1', 'AEBP2', 'MTF2', 'RARB', 'TCF4', 'WDFY2', 'BMPR1A']",0.004656858068734296,0,0,25
4,Endoderm differentiation WP2853,4.827701887979546e-05,2.7379565687661205,27.211331700218004,"['NCAPG2', 'FOXO1', 'ACACA', 'CDC73', 'MBTD1', 'EPB41L5', 'JARID2', 'BPTF', 'MAP2K3', 'SMAD2', 'CDYL', 'EMSY', 'PIAS1', 'EXT1', 'TNRC6C', 'TOX3', 'DDAH1', 'AEBP2', 'APC', 'RFX7', 'MTF2', 'TCF4', 'WDFY2', 'NAA15', 'BMPR1A']",0.005720826737255762,0,0,25
5,Pathways affected in adenoid cystic carcinoma WP3651,0.0001233720150805861,3.4529082024546898,31.077231290349495,"['SETD2', 'CREBBP', 'FBXW7', 'KMT2C', 'ATRX', 'PTEN', 'ERBIN', 'ARID4B', 'FOXP2', 'NCOR1', 'KAT6A', 'NSD1', 'CHEK1', 'EP300', 'TLK1', 'ATM']",0.010225839704166535,0,0,16
6,EGF/EGFR signaling pathway WP437,0.00012944100891350044,2.3098850952260848,20.678750406323946,"['ATF1', 'RALA', 'ROCK1', 'SH3KBP1', 'PTEN', 'FOXO1', 'EGFR', 'ATXN2', 'PAK1', 'RPS6KA2', 'ABL1', 'NCK2', 'PLCE1', 'MAPK1', 'JAK2', 'MAP3K4', 'MEF2A', 'MAP3K2', 'USP8', 'STAT5B', 'MEF2C', 'PRKCI', 'MAP3K1', 'PRKCA', 'GAB2', 'PTK2', 'ITCH', 'RPS6KB1', 'SOS1', 'SOS2']",0.010225839704166535,0,0,30
7,Energy Metabolism WP1541,0.00026505267460378223,3.76507713884993,31.00760143667026,"['MEF2A', 'GSK3B', 'PRKAA1', 'MEF2C', 'HDAC1', 'NRF1', 'TFB1M', 'FOXO1', 'PPP3CC', 'PPP3R2', 'EP300', 'PPARA', 'PPARGC1A']",0.017947852537456108,0,0,13
8,Leptin signaling pathway WP2034,0.0003288858709442484,2.9763421171350477,23.86966780920056,"['GSK3B', 'PTPN1', 'STAT5B', 'PRKAA1', 'CHUK', 'ROCK1', 'RPS6', 'PTEN', 'FOXO1', 'ACACA', 'PTK2', 'SOCS2', 'RPS6KB1', 'MAPK1', 'FYN', 'JAK2', 'SOS1']",0.018649830271784764,0,0,17
9,Chemokine signaling pathway WP3929,0.0003541107013630019,2.4571644262614454,19.524385217740512,"['STAT5B', 'GSK3B', 'CHUK', 'ROCK1', 'GNAI3', 'PIK3R3', 'PIK3CB', 'RASGRP2', 'PTK2', 'ADCY5', 'TIAM2', 'TIAM1', 'PAK1', 'ADCY9', 'PLCB4', 'GRK5', 'GRK4', 'GNB2', 'ELMO1', 'MAPK1', 'JAK2', 'SOS1', 'SOS2']",0.018649830271784764,0,0,23
10,Joubert Syndrome WP4656,0.0003935670198748167,2.9210032817627756,22.90142281587266,"['INVS', 'ARMC9', 'MYO5A', 'CPLANE1', 'RPGRIP1L', 'AHI1', 'NIN', 'ARL13B', 'KIAA0586', 'SUFU', 'TMEM67', 'MYO6', 'INPP5E', 'NPHP4', 'ATM', 'CEP290', 'PIBF1']",0.01865507674206631,0,0,17
11,ErbB signaling pathway WP673,0.0006381672600937403,2.593413421706711,19.079509514464807,"['GSK3B', 'MAP2K4', 'STAT5B', 'PIK3R3', 'PRKCA', 'PIK3CB', 'NRG2', 'FOXO1', 'EGFR', 'PTK2', 'PAK1', 'RPS6KB1', 'NCK2', 'ABL1', 'MAPK1', 'SOS1', 'PAK3', 'SOS2', 'PAK5']",0.027499207389493904,0,0,19
12,Alzheimer's disease WP2059,0.0013674183882528613,2.6487300471840176,17.467926244350085,"['GSK3B', 'EIF2AK3', 'ADAM10', 'ITPR2', 'IDE', 'CACNA1C', 'GRIN2B', 'VMP1', 'ADAM17', 'GRIN2A', 'PPP3CC', 'PLCB4', 'PPP3R2', 'GNAQ', 'MAPK1', 'ATF6']",0.05048884936721126,0,0,16
13,Ectoderm Differentiation WP2858,0.0014511300070566148,2.220183486238532,14.509815376375064,"['BCAS3', 'NLGN1', 'KCNK10', 'ELOVL4', 'C1GALT1', 'ARHGDIG', 'SOCS2', 'TRPM2', 'AHI1', 'TOX3', 'PTPRB', 'RIT1', 'NARS2', 'FYN', 'NF2', 'KIFC3', 'PDE7A', 'PGM1', 'TRIM33', 'CDON', 'ASTN1', 'BMPR1A']",0.05048884936721126,0,0,22
14,Gastrin signaling pathway WP4659,0.0014912318378501217,2.3199436222692036,15.098547497064791,"['GSK3B', 'MEF2C', 'YES1', 'CHUK', 'ROCK1', 'PRKCE', 'RPS6', 'PIK3R3', 'PRKCA', 'FOXO1', 'PTK2', 'EGFR', 'PAK1', 'RPS6KB1', 'GNAQ', 'MAPK1', 'TCF4', 'FYN', 'JAK2', 'SOS1']",0.05048884936721126,0,0,20
15,TNF-alpha signaling pathway WP231,0.0016562122282827302,2.5020092425155718,16.02092081116518,"['MAP2K3', 'MAP2K4', 'CREBBP', 'MAP3K1', 'KSR1', 'CHUK', 'FBXW11', 'CUL1', 'OTUD7B', 'KSR2', 'TBK1', 'MAPK1', 'BTRC', 'SOS1', 'MAP3K7', 'MAP3K5', 'NSMAF']",0.052336306413734275,0,0,17
16,G13 Signaling Pathway WP524,0.0018587817909883324,3.558701620283146,22.376524890536697,"['GNA13', 'CYFIP1', 'DIAPH1', 'ROCK1', 'RPS6KB1', 'ARHGDIG', 'PIP4K2A', 'PIK3CB', 'PAK3', 'MAP3K4']",0.05428569463512472,0,0,10
17,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.002052216857318774,2.149582141663262,13.303408497887016,"['MAP2K3', 'MAP3K2', 'MAP2K4', 'GSK3B', 'PTPN1', 'PRKAA1', 'MAP3K1', 'PIK3R3', 'PIK3CB', 'FOXO1', 'RPTOR', 'SESN3', 'RPS6KB1', 'RPS6KA2', 'MAPK1', 'MAP3K9', 'SOS1', 'MAP3K7', 'SOS2', 'MAP3K4', 'MAP3K5', 'MAP4K4']",0.05428569463512472,0,0,22
18,Prolactin Signaling Pathway WP2037,0.0020614820747515716,2.62249576001696,16.218379468681423,"['GSK3B', 'PTPN1', 'STAT5B', 'RPS6', 'PIK3CB', 'GAB2', 'PTK2', 'SOCS2', 'PAK1', 'RPS6KB1', 'RPS6KA2', 'MAPK1', 'FYN', 'JAK2', 'SOS1']",0.05428569463512472,0,0,15
19,Regulation of Actin Cytoskeleton WP51,0.0022086713637026814,2.093428049185776,12.802074815665486,"['NCKAP1', 'PPP1R12A', 'ROCK1', 'RDX', 'PIK3R3', 'PIK3CB', 'ARHGAP35', 'PTK2', 'FGD1', 'EGFR', 'GNA13', 'DIAPH1', 'PAK1', 'FGF14', 'APC', 'PIP4K2A', 'MAPK1', 'SOS1', 'ARHGEF7', 'PAK3', 'MYH10', 'SOS2', 'PAK5']",0.055100538231319524,0,0,23
20,Insulin Signaling WP481,0.002342892918353928,1.9797199308528535,11.989914068072494,"['GSK3B', 'PRKAA1', 'PTEN', 'PIK3R3', 'PIK3CB', 'FOXO1', 'CYTH3', 'RPS6KA2', 'MAPK1', 'MAP3K9', 'MAP3K7', 'MAP3K4', 'MAP3K5', 'MAP4K4', 'MAP2K3', 'MAP3K2', 'MAP2K4', 'PTPN1', 'PRKCI', 'MAP3K1', 'PRKCA', 'INPP4A', 'RPS6KB1', 'SOS1', 'SGK1', 'SOS2']",0.055526562164988094,0,0,26
21,15q13.3 copy number variation syndrome WP4942,0.0024991335802978325,7.695258019525802,46.10853299634459,"['KAT2B', 'MTMR10', 'CREBBP', 'OTUD7A', 'FYN']",0.05640901509815108,0,0,5
22,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.0028777600691167688,2.0073727437685034,11.744622111739403,"['MEF2A', 'MAP3K2', 'CYFIP1', 'STAT5B', 'GSK3B', 'MEF2C', 'PRKAA1', 'DOCK3', 'MAP3K1', 'KSR1', 'CHUK', 'NTRK3', 'RPS6', 'RANBP9', 'GRIN2B', 'TIAM1', 'ADAM17', 'RPS6KB1', 'APC', 'NCK2', 'MAPK1', 'FYN', 'JAK2', 'GRIA3']",0.05831054665556759,0,0,24
23,IL-6 signaling pathway WP364,0.0028855088933515756,3.3040087973607917,19.322021869172197,"['GSK3B', 'MAP2K4', 'CREBBP', 'RPS6KB1', 'HDAC1', 'MAPK1', 'PRDM1', 'JAK2', 'SOS1', 'MAP3K7']",0.05831054665556759,0,0,10
24,Interactome of polycomb repressive complex 2 (PRC2)  WP2916,0.0029524327420540554,5.542777390090719,32.28737552408247,"['MORC3', 'AEBP2', 'EED', 'MTF2', 'STK38', 'JARID2']",0.05831054665556759,0,0,6
25,Phosphoinositides metabolism WP4971,0.0034021674778772697,2.993779864887131,17.01467651234097,"['MTMR10', 'PLCB4', 'MTMR3', 'MTMR12', 'PTEN', 'PIP4K2A', 'PLCE1', 'PIK3CB', 'PLCH2', 'MTM1', 'MTMR7']",0.06202413017360868,0,0,11
26,Translation inhibitors in chronically activated PDGFRA cells WP4566,0.0034021674778772697,2.993779864887131,17.01467651234097,"['RPTOR', 'MAP2K3', 'MAP2K4', 'RPS6KB1', 'RPS6KA2', 'RPS6', 'PIK3R3', 'MAPK1', 'PRKCA', 'PIK3CB', 'PDK1']",0.06202413017360868,0,0,11
27,MECP2 and Associated Rett Syndrome WP3584,0.004822484845332227,2.4459450513075143,13.047810605667205,"['MEF2C', 'RBFOX1', 'GRID1', 'HDAC1', 'FUS', 'RPS6', 'PTEN', 'TET2', 'FUT8', 'NCOR1', 'SP3', 'SGK1', 'GRIA3', 'CDON']",0.07958220292046277,0,0,14
28,Pathways in clear cell renal cell carcinoma WP4018,0.004858281769217462,2.3547300514187772,12.543812872309141,"['SETD2', 'PBRM1', 'CREBBP', 'KSR1', 'PTEN', 'ARNT', 'ACACA', 'EGFR', 'RPTOR', 'PKM', 'EP300', 'ENPP3', 'CEP290', 'PGM1', 'PSPH']",0.07958220292046277,0,0,15
29,Synaptic signaling pathways associated with autism spectrum disorder WP4539,0.004868953343235063,2.82703081232493,15.053589327363834,"['RPTOR', 'GSK3B', 'PRKAA1', 'GRIN2A', 'RPS6KB1', 'PTEN', 'PIK3R3', 'MAPK1', 'PIK3CB', 'CACNA1C', 'GRIN2B']",0.07958220292046277,0,0,11
30,Histone Modifications WP2369,0.0052227454514893815,2.9835887943294432,15.677959711674877,"['KMT2E', 'SETD2', 'SETBP1', 'AEBP2', 'EED', 'KMT2C', 'NSD1', 'EHMT1', 'ASH1L', 'SMYD3']",0.08251937813353223,0,0,10
31,Androgen receptor signaling pathway WP138,0.005462544510627751,2.245703698971443,11.6997582395383,"['RB1', 'GSK3B', 'CREBBP', 'ROCK1', 'HDAC1', 'PTEN', 'NR2C2', 'PIAS2', 'FOXO1', 'EGFR', 'PTK2', 'PIAS1', 'KAT2B', 'NCOR1', 'ZNF318', 'EP300']",0.08352406767863077,0,0,16
32,Envelope proteins and their potential roles in EDMD physiopathology WP4535,0.007463841173765059,2.802341115847064,13.724984313163835,"['SMAD2', 'SUN1', 'ADCY9', 'MAPK1', 'MAP3K9', 'SOS1', 'SOS2', 'SYNE1', 'ADCY5', 'PLEC']",0.1079526294727547,0,0,10
33,Biotin Metabolism (including IEMs) WP5031,0.007722574774400062,7.382857142857143,35.90731900635275,"['PC', 'PCCA', 'HLCS', 'ACACA']",0.1079526294727547,0,0,4
34,Hematopoietic Stem Cell Gene Regulation by GABP alpha/beta Complex WP3657,0.007743437557117426,4.26270868001503,20.720641379082053,"['CREBBP', 'PTEN', 'EP300', 'ATM', 'ZFX', 'ETV6']",0.1079526294727547,0,0,6
35,Non-small cell lung cancer WP4255,0.008209736603134251,2.2736103416435824,10.918864604385494,"['ALK', 'RB1', 'STAT5B', 'PIK3R3', 'PRKCA', 'PIK3CB', 'FHIT', 'EGFR', 'EML4', 'RARB', 'MAPK1', 'SOS1', 'SOS2', 'PDK1']",0.11107539374539101,0,0,14
36,MAPK Cascade WP422,0.00843610585408033,3.214535290006988,15.350159717195073,"['MAP3K2', 'MAP2K3', 'MAP2K4', 'MAP3K1', 'MAP2', 'MAPK1', 'SOS1', 'SOS2']",0.11107539374539101,0,0,8
37,Ras signaling WP4223,0.009345932640839737,1.795144192408526,8.388374989703937,"['RALA', 'KSR1', 'CHUK', 'PIK3R3', 'PRKCA', 'PIK3CB', 'KSR2', 'GAB2', 'RASGRP2', 'GRIN2B', 'EGFR', 'TIAM1', 'GRIN2A', 'PAK1', 'GNB2', 'RASA2', 'ABL1', 'PLCE1', 'MAPK1', 'SHOC2', 'SOS1', 'PAK3', 'SOS2', 'PAK5']",0.11972897491237933,0,0,24
38,Interleukin-11 Signaling Pathway WP2332,0.00965042331476505,2.868844948155293,13.313602227735373,"['ATF1', 'YES1', 'CHUK', 'RPS6KB1', 'RPS6', 'MAPK1', 'FYN', 'JAK2', 'PIAS1']",0.12037633292627983,0,0,9
39,Follicle Stimulating Hormone (FSH) signaling pathway WP2035,0.01016119131846665,3.957930415711295,18.163653474313197,"['RPS6KB1', 'RPS6', 'MAPK1', 'PRKCA', 'SGK1', 'FOXO1']",0.12349755602444082,0,0,6
40,Ciliopathies WP4803,0.01098452179130883,1.7434409928640555,7.865129747497906,"['INVS', 'IFT172', 'PKD2', 'TTBK2', 'ARL13B', 'SUFU', 'TMEM67', 'INPP5E', 'NEK1', 'NPHP4', 'PIBF1', 'CEP290', 'CEP78', 'IFT140', 'SCLT1', 'DNAAF5', 'CPLANE1', 'RPGRIP1L', 'AHI1', 'WDR60', 'KIAA0586', 'ALMS1', 'EFHC1', 'SPAG1', 'SDCCAG8']",0.13016658322700964,0,0,25
41,MAP3K1 role in promoting and blocking gonadal determination WP4872,0.011648122397463904,4.615760111576011,20.55218092078168,"['GSK3B', 'MAP3K1', 'ROCK1', 'MAPK1', 'MAP3K4']",0.13466365893653393,0,0,5
42,DNA damage response (only ATM dependent) WP710,0.012081102407345858,2.0292840708901703,8.961547424730167,"['GSK3B', 'MAP3K1', 'PTEN', 'PIK3R3', 'PIK3CB', 'PPP2R5C', 'APC', 'PPP2R5E', 'ABL1', 'MAPK1', 'ATM', 'SOS1', 'MAP3K7', 'SOS2', 'MAP3K4', 'PDK1']",0.1363438700257604,0,0,16
43,G Protein Signaling Pathways WP35,0.012690707817859258,2.0723104980714404,9.049542087770492,"['PRKCI', 'PRKCE', 'GNAI3', 'PRKCA', 'ADCY5', 'GNA13', 'PPP3CC', 'ADCY9', 'PRKAR2B', 'PRKAR2A', 'GNB2', 'GNAQ', 'AKAP9', 'PDE7A', 'KCNJ3']",0.13989291873640206,0,0,15
44,PI3K-AKT-mTOR signaling pathway and therapeutic opportunities WP3844,0.016043664599922708,3.0789106145251397,12.723417186372801,"['RPTOR', 'GSK3B', 'PTEN', 'PIK3R3', 'PIK3CB', 'FOXO1', 'PDK1']",0.17283402319007646,0,0,7
45,EPO Receptor Signaling WP581,0.016514573021588277,3.462665736217725,14.20909065835196,"['STAT5B', 'MAPK1', 'JAK2', 'SOS1', 'EPOR', 'PDK1']",0.1739535024940632,0,0,6
46,Fragile X Syndrome  WP4549,0.017450862479125473,1.8140627268767242,7.343990238720442,"['CYFIP1', 'ABCD3', 'KCNC1', 'PTEN', 'PRKCA', 'DICER1', 'PIK3CB', 'GRIN2B', 'GRIP2', 'DNM2', 'RPTOR', 'GRIN2A', 'RPS6KB1', 'MKNK1', 'MAPK1', 'FYN', 'SOS1', 'PDK1', 'SHANK1']",0.179819756850119,0,0,19
47,Prion disease pathway WP3995,0.019407233759305316,2.938737938039614,11.584826473845366,"['PRNP', 'MEF2C', 'EP300', 'MAPK1', 'FYN', 'CHD2', 'PTK2']",0.19120928389830374,0,0,7
48,MAPK Signaling Pathway WP382,0.020072042141776575,1.5633846620042902,6.11037540342502,"['CACNA1B', 'CACNA1C', 'RASGRP2', 'EGFR', 'CACNA1I', 'CACNG7', 'PAK1', 'PPP3R2', 'PPP3CC', 'MKNK1', 'MAPK1', 'MAP3K7', 'MAP3K4', 'MAP4K4', 'MAP3K5', 'MAP3K2', 'MAP2K3', 'MAP2K4', 'MEF2C', 'MAP3K1', 'CHUK', 'CACNA2D2', 'PRKCA', 'CACNB2', 'PPM1B', 'FGF14', 'TAOK1', 'RASA2', 'SOS1', 'SOS2']",0.19120928389830374,0,0,30
49,"4-hydroxytamoxifen, Dexamethasone, and Retinoic Acids Regulation of p27 Expression WP3879",0.02035572534135243,3.8458856345885635,14.97739033684767,"['MAP2K3', 'PRKAA1', 'MKNK1', 'MAPK1', 'MAP3K5']",0.19120928389830374,0,0,5
50,Sleep regulation WP3591,0.02053678361274894,3.2587332211321374,12.661930713710001,"['CACNA1I', 'NLGN1', 'GRIN2A', 'PER3', 'DRD1', 'BTBD9']",0.19120928389830374,0,0,6
51,Integrated breast cancer pathway WP1984,0.020573150799184578,1.7214511277257012,6.685717513628449,"['ATF1', 'RB1', 'SMAD2', 'RALA', 'USP15', 'BMPR2', 'CHUK', 'HDAC1', 'MYCBP2', 'PTEN', 'FOXO1', 'EGFR', 'PIAS1', 'PAK1', 'RASGEF1A', 'CHEK1', 'ABL1', 'EP300', 'MAPK1', 'ATM', 'BMPR1A']",0.19120928389830374,0,0,21
52,Kit receptor signaling pathway WP304,0.021408902127739105,2.310706787963611,8.882237790267025,"['STAT5B', 'RPS6KB1', 'RPS6', 'EP300', 'MAPK1', 'PRKCA', 'FYN', 'GAB2', 'JAK2', 'SOS1']",0.195150377087468,0,0,10
53,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.022578664504378773,1.9622328548644339,7.43833393375173,"['GSK3B', 'RPS6', 'PTEN', 'PIK3R3', 'PRKCA', 'PIK3CB', 'NRG2', 'EGFR', 'RPS6KB1', 'PDGFD', 'MAPK1', 'JAK2', 'SOS1', 'SOS2']",0.20192994292595356,0,0,14
54,Circadian rhythm related genes WP3594,0.023302376919374066,1.65186900538694,6.2097058162279,"['GSK3B', 'NLGN1', 'PRKAA1', 'PHLPP1', 'FBXW11', 'KCNH7', 'HDAC1', 'NTRK3', 'CUL1', 'PTEN', 'ARNT', 'RORA', 'BTBD9', 'NCOR1', 'PER3', 'GNAQ', 'EP300', 'DRD1', 'BTRC', 'PPARA', 'CLOCK', 'PPARGC1A', 'LGR4']",0.2045430862922835,0,0,23
55,Regulation of Wnt/B-catenin Signaling by Small Molecule Compounds WP3664,0.023896898744464976,4.613240418118467,17.22587011378969,"['GSK3B', 'APC', 'TNKS', 'TCF4']",0.20594781827048,0,0,4
56,Notch Signaling Pathway Netpath WP61,0.024368878239739974,2.254177405314991,8.373025752922862,"['GSK3B', 'ADAM17', 'ITCH', 'NCOR1', 'FBXW7', 'HDAC1', 'NUMB', 'CUL1', 'EP300', 'JAK2']",0.20626514795779904,0,0,10
57,Copper homeostasis WP3286,0.02829765221213758,2.3097902097902097,8.234347675725157,"['GSK3B', 'PRNP', 'ADAM17', 'ATP7B', 'APC', 'MTF2', 'PTEN', 'ADAM10', 'FOXO1']",0.2315949684632899,0,0,9
58,Cell cycle WP179,0.028338624833060787,1.8053236892172155,6.4333243495557815,"['RB1', 'SMAD2', 'GSK3B', 'HDAC1', 'CUL1', 'ANAPC10', 'ORC5', 'STAG2', 'RBL1', 'TFDP2', 'CDC27', 'CHEK1', 'ORC2', 'ABL1', 'EP300', 'ATM']",0.2315949684632899,0,0,16
59,IL-2 signaling pathway WP49,0.0323789459691999,2.5855027932960892,8.868912898133983,"['STAT5B', 'RPS6KB1', 'RPS6', 'MAPK1', 'FYN', 'GAB2', 'SOS1']",0.25654508628745126,0,0,7
60,Hereditary leiomyomatosis and renal cell carcinoma pathway WP4206,0.03247406155537358,3.295975293883244,11.29634099709313,"['EGLN1', 'PRKAA1', 'RPS6', 'ACACA', 'PDK1']",0.25654508628745126,0,0,5
61,Hepatitis B infection WP4666,0.03317844814004399,1.699722816642491,5.789009056380423,"['MAP2K3', 'SMAD2', 'MAP2K4', 'STAT5B', 'CREBBP', 'MAP3K1', 'CHUK', 'PIK3R3', 'PRKCA', 'PIK3CB', 'TBK1', 'TRAF3', 'EP300', 'MAPK1', 'JAK2', 'SOS1', 'MAP3K7', 'SOS2']",0.25781285931771886,0,0,18
62,NLR Proteins WP288,0.03607166848854092,5.5332869080779945,18.38294875305452,"['CHUK', 'ERBIN', 'MAP3K7']",0.2640067769207645,0,0,3
63,Genes related to primary cilium development (based on CRISPR) WP4536,0.03633035257333904,1.741209540738291,5.772286757402845,"['IFT140', 'IFT172', 'ARMC9', 'SCLT1', 'CPLANE1', 'RPGRIP1L', 'TTBK2', 'IFT88', 'ARL13B', 'WDR60', 'TMEM67', 'INPP5E', 'SASS6', 'FGFR1OP', 'CEP192', 'PIBF1']",0.2640067769207645,0,0,16
64,Male infertility WP4673,0.036344968174755535,1.778576058772688,5.8954451935154175,"['USP8', 'CREBBP', 'PACRG', 'CCNT2', 'HMGA1', 'TEX15', 'CHD2', 'PUM2', 'ABLIM1', 'EP300', 'SLC16A7', 'ATM', 'RGS9', 'CLOCK', 'SOX5']",0.2640067769207645,0,0,15
65,Disruption of postsynaptic signaling by CNV WP4875,0.037741548820334904,2.4858723678556083,8.146188090105744,"['CYFIP1', 'NLGN1', 'GRIN2A', 'NLGN4X', 'MAPK1', 'GRIN2B', 'SHANK1']",0.2640067769207645,0,0,7
66,Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway WP2203,0.037741548820334904,2.4858723678556083,8.146188090105744,"['STAT5B', 'YES1', 'RPS6', 'MAPK1', 'FYN', 'GAB2', 'JAK2']",0.2640067769207645,0,0,7
67,Type 2 papillary renal cell carcinoma WP4241,0.037741548820334904,2.4858723678556083,8.146188090105744,"['EGLN1', 'DIAPH1', 'SETD2', 'CREBBP', 'CADM2', 'EP300', 'ARNT']",0.2640067769207645,0,0,7
68,Calcium Regulation in the Cardiac Cell WP536,0.03787438993799997,1.6432736606555218,5.379223664032717,"['PRKCE', 'CACNA1B', 'GNAI3', 'ITPR2', 'PRKCA', 'ATP2B2', 'CACNA1C', 'SLC8A1', 'ADCY5', 'ADCY9', 'GRK5', 'PRKAR2B', 'GRK4', 'PRKAR2A', 'GNB2', 'GNAQ', 'ANXA6', 'RGS9', 'KCNJ3']",0.2640067769207645,0,0,19
69,3q29 copy number variation syndrome WP4906,0.0391636380233522,2.053184044786564,6.652329782453426,"['STAT5B', 'TFRC', 'FBXW7', 'WDR60', 'DYNLT3', 'MYCBP2', 'ADAM10', 'PIK3R3', 'FGFR1OP', 'NF2']",0.26519377747241346,0,0,10
70,AGE/RAGE pathway WP2324,0.0391636380233522,2.053184044786564,6.652329782453426,"['SMAD2', 'STAT5B', 'DIAPH1', 'CHUK', 'ROCK1', 'MAPK1', 'PRKCA', 'JAK2', 'FOXO1', 'EGFR']",0.26519377747241346,0,0,10
71,T-Cell Receptor and Co-stimulatory Signaling WP2583,0.039911694550885876,3.0760111576011155,9.908096172658803,"['GSK3B', 'PTEN', 'FYN', 'PRKCA', 'PDK1']",0.26530396332693895,0,0,5
72,Rett syndrome causing genes WP4312,0.041195543286472715,2.1316299085529855,6.79867414983448,"['KDM5B', 'GRIN2A', 'MEF2C', 'NCOR1', 'TRRAP', 'HDAC1', 'TBL1XR1', 'TCF4', 'GRIN2B']",0.26530396332693895,0,0,9
73,IL17 signaling pathway WP2112,0.043078515299676275,2.6372246037284417,8.293361678070681,"['GSK3B', 'TRAF3', 'MAPK1', 'JAK2', 'MAP3K7', 'IL17RC']",0.26530396332693895,0,0,6
74,ATM Signaling Pathway WP2516,0.04365535293194846,2.3936219739292364,7.495458152666283,"['PIDD1', 'CRADD', 'CHEK1', 'ABL1', 'CASP2', 'TLK1', 'ATM']",0.26530396332693895,0,0,7
75,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.04365535293194846,2.3936219739292364,7.495458152666283,"['MAP2K3', 'MAP2K4', 'MAP3K1', 'RPS6KA2', 'MAPK1', 'MAP3K9', 'MAP3K4']",0.26530396332693895,0,0,7
76,IL-5 signaling pathway WP127,0.04365535293194846,2.3936219739292364,7.495458152666283,"['GSK3B', 'STAT5B', 'RPS6KB1', 'RPS6', 'MAPK1', 'JAK2', 'SOS1']",0.26530396332693895,0,0,7
77,Vitamin D-sensitive calcium signaling in depression WP4698,0.04365535293194846,2.3936219739292364,7.495458152666283,"['GRIN2A', 'KCNQ3', 'ITPR2', 'ATP2B2', 'CACNA1C', 'GRIN2B', 'SLC8A1']",0.26530396332693895,0,0,7
78,MET in type 1 papillary renal cell carcinoma WP4205,0.043657614218357045,2.0083974807557734,6.2890508307498685,"['ALK', 'PAK1', 'PIK3R3', 'MAPK1', 'PIK3CB', 'SOS1', 'PAK3', 'SOS2', 'PAK5', 'PTK2']",0.26530396332693895,0,0,10
79,PKC-gamma calcium signaling pathway in ataxia WP4760,0.048299763117708124,2.883542538354254,8.738081488837048,"['PLCB4', 'GNAQ', 'ATP2B2', 'GRIA3', 'PDK1']",0.2817598148869343,0,0,5
80,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850,0.05013461760262707,2.3079608938547485,6.90782744251428,"['RPTOR', 'SMAD2', 'GSK3B', 'RPS6KB1', 'PTEN', 'PPARGC1A', 'PDK1']",0.2817598148869343,0,0,7
81,Fas ligand pathway and stress induction of heat shock proteins WP314,0.05013461760262707,2.3079608938547485,6.90782744251428,"['RB1', 'MAP2K4', 'PAK1', 'MAP3K1', 'CASP6', 'FAF1', 'MAP3K7']",0.2817598148869343,0,0,7
82,Netrin-UNC5B signaling pathway WP4747,0.05013461760262707,2.3079608938547485,6.90782744251428,"['DAPK1', 'MAPK1', 'PRKCA', 'FYN', 'NEO1', 'RLF', 'PTK2']",0.2817598148869343,0,0,7
83,Sulindac Metabolic Pathway WP2542,0.05032667308811441,9.217814892136396,27.554077206542285,"['MSRA', 'MSRB3']",0.2817598148869343,0,0,2
84,Neural Crest Cell Migration during Development WP4564,0.05045166365159841,2.517160439002728,7.518102653177186,"['TIAM1', 'PAK1', 'PIK3R3', 'PIK3CB', 'PAK3', 'PAK5']",0.2817598148869343,0,0,6
85,Hippo-Merlin Signaling Dysregulation WP4541,0.05052654908310003,1.7255859649122807,5.151316470316755,"['PPP1R12A', 'PTK2', 'EGFR', 'DCAF1', 'LATS1', 'CUL4A', 'PAK1', 'PLCB4', 'PRKAR2B', 'PRKAR2A', 'ITGA8', 'NF2', 'PAK3', 'PAK5']",0.2817598148869343,0,0,14
86,Cardiac Hypertrophic Response WP2795,0.051706272691261754,2.0273409517311958,6.005341068204899,"['MEF2A', 'MAP2K3', 'GSK3B', 'MAP2K4', 'MAP3K1', 'CHUK', 'MAPK1', 'PRKCA', 'MAP3K7']",0.283643254269925,0,0,9
87,MAPK pathway in congenital thyroid cancer WP4928,0.052061103631821676,3.3543237250554325,9.91315761979503,"['ALK', 'KSR1', 'SOS1', 'SOS2']",0.283643254269925,0,0,4
88,Ebola Virus Pathway on Host WP4217,0.053982247197976334,1.670798361987275,4.877227568755613,"['CREBBP', 'TSG101', 'DAB2IP', 'PIK3R3', 'PIK3CB', 'MERTK', 'EGFR', 'TIAM1', 'ADAM17', 'PAK1', 'TBK1', 'RASA2', 'EP300', 'MAPK1', 'KPNA1']",0.29076801331637253,0,0,15
89,Pathways Regulating Hippo Signaling WP4540,0.055097130177336584,1.741234221598878,5.047241893528499,"['SMAD2', 'PRKCI', 'PRKAA1', 'PRKCE', 'GNAI3', 'PRKCA', 'EGFR', 'LATS1', 'PLCB4', 'PRKAR2B', 'PRKAR2A', 'GNAQ', 'NF2']",0.2934386483601971,0,0,13
90,Glycogen Synthesis and Degradation WP500,0.05719016058964573,2.228207474475053,6.375733626237034,"['GSK3B', 'PPP2R5E', 'AGL', 'PHKB', 'PPP2R5C', 'PHKA2', 'PGM1']",0.2935590247160762,0,0,7
91,Nanoparticle triggered autophagic cell death WP2509,0.057648357647196544,2.713717286077611,7.743303321954598,"['VMP1', 'UVRAG', 'ATG10', 'AMBRA1', 'ATG5']",0.2935590247160762,0,0,5
92,Physiological and pathological hypertrophy of the heart WP1528,0.057648357647196544,2.713717286077611,7.743303321954598,"['MAP2K3', 'MYEF2', 'PRKCE', 'MAPK1', 'LIFR']",0.2935590247160762,0,0,5
93,Melatonin metabolism and effects WP3298,0.05855021768449246,2.4075366364270763,6.832277128416659,"['GSK3B', 'PER3', 'MAP2', 'PRKCA', 'CLOCK', 'FOXO1']",0.2935590247160762,0,0,6
94,PDGFR-beta pathway WP3972,0.05855021768449246,2.4075366364270763,6.832277128416659,"['STAT5B', 'MAP2K4', 'MAP3K1', 'PRKCA', 'JAK2', 'SOS1']",0.2935590247160762,0,0,6
95,Integrin-mediated Cell Adhesion WP185,0.05973210646787623,1.7162292125826488,4.836137595355658,"['MAP2K3', 'ROCK1', 'PTK2', 'PAK1', 'CAPN7', 'SELENOP', 'ITGA8', 'MAPK1', 'FYN', 'SOS1', 'ARHGEF7', 'PAK3', 'TNS1']",0.2935590247160762,0,0,13
96,Pancreatic adenocarcinoma pathway WP4263,0.05973210646787623,1.7162292125826488,4.836137595355658,"['RB1', 'SMAD2', 'RALA', 'CHUK', 'PIK3R3', 'PIK3CB', 'EGFR', 'TIAM1', 'PAK1', 'RPS6KB1', 'MAPK1', 'PAK3', 'PAK5']",0.2935590247160762,0,0,13
97,Corticotropin-releasing hormone signaling pathway WP2355,0.060074315184513484,1.7599359295224748,4.9492441210492615,"['GSK3B', 'PRKCI', 'GRK3', 'TRIM28', 'GNB2', 'GNAQ', 'MAPK1', 'PRKCA', 'TCF4', 'ACACA', 'PTK2', 'MAP3K5']",0.2935590247160762,0,0,12
98,IL-4 signaling pathway WP395,0.06137923431060309,2.0517120894479386,5.725679494231235,"['STAT5B', 'CHUK', 'RPS6KB1', 'EP300', 'MAPK1', 'GAB2', 'JAK2', 'SOS1']",0.2968750720737333,0,0,8
99,Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms WP4534,0.06482927721586097,2.1537709497206703,5.89271294363604,"['LATS1', 'PAK1', 'SGMS1', 'NF2', 'PAK3', 'PAK5', 'MAP4K4']",0.31039472121533435,0,0,7
100,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.06737929522345464,2.3070481507327285,6.22307205694593,"['PLCB4', 'PRKCE', 'MAPK1', 'PRKCA', 'PIK3CB', 'PDK1']",0.319377859359175,0,0,6
101,Glioblastoma signaling pathways WP2261,0.07075364741590587,1.7055253086087003,4.517171086041896,"['RB1', 'MAP2K3', 'MAP2K4', 'PRKCI', 'PTEN', 'EP300', 'MAPK1', 'PRKCA', 'ATM', 'PIK3CB', 'FOXO1', 'EGFR']",0.33205177104098393,0,0,12
102,Integrated Cancer Pathway WP1971,0.07305570710595491,2.0841367814020546,5.453212702180019,"['ATF1', 'RB1', 'SMAD2', 'CHEK1', 'PTEN', 'ATM', 'MAP3K5']",0.3361981084293459,0,0,7
103,PDGF Pathway WP2526,0.07305570710595491,2.0841367814020546,5.453212702180019,"['MAP2K4', 'TIAM1', 'PAK1', 'MAP3K1', 'CHUK', 'MAPK1', 'SOS1']",0.3361981084293459,0,0,7
104,miRNA regulation of prostate cancer signaling pathways WP3981,0.07693833883457973,2.2145987438939287,5.679894281637797,"['GSK3B', 'CREBBP', 'PLCL2', 'MAPK1', 'SOS1', 'FOXO1']",0.3382701544436127,0,0,6
105,Neural Crest Cell Migration in Cancer WP4565,0.07693833883457973,2.2145987438939287,5.679894281637797,"['TIAM1', 'PAK1', 'PIK3R3', 'PIK3CB', 'PAK3', 'PAK5']",0.3382701544436127,0,0,6
106,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.07762229159033593,1.8465734265734266,4.7196581848427686,"['GSK3B', 'MAP2K4', 'PAK1', 'DAAM1', 'APC', 'MAPK1', 'SOS1', 'EGFR', 'PTK2']",0.3382701544436127,0,0,9
107,Proteoglycan biosynthesis WP4784,0.07770962163326767,2.837845081747521,7.2500590705341645,"['EXT1', 'EXT2', 'CHSY1', 'PAPSS2']",0.3382701544436127,0,0,4
108,Eicosanoid metabolism via cytochrome P450 monooxygenases (CYP) pathway WP4720,0.07850151263459365,6.144745998608212,15.636150390302758,"['PPARA', 'CYP2C18']",0.3382701544436127,0,0,2
109,FTO Obesity Variant Mechanism WP3407,0.07850151263459365,6.144745998608212,15.636150390302758,"['FTO', 'PPARGC1A']",0.3382701544436127,0,0,2
110,TCA Cycle Nutrient Utilization and Invasiveness of Ovarian Cancer WP2868,0.07850151263459365,6.144745998608212,15.636150390302758,"['MAPK1', 'EGFR']",0.3382701544436127,0,0,2
111,Glycolysis in senescence WP5049,0.08522880712399139,3.4575208913649025,8.513854038914587,"['RB1', 'PRKAA1', 'PKM']",0.35750844758205236,0,0,3
112,Leptin Insulin Overlap WP3935,0.08522880712399139,3.4575208913649025,8.513854038914587,"['SOCS2', 'PIK3R3', 'JAK2']",0.35750844758205236,0,0,3
113,MAPK and NFkB signaling pathways inhibited by Yersinia YopJ WP3849,0.08522880712399139,3.4575208913649025,8.513854038914587,"['MAP3K1', 'CHUK', 'MAPK1']",0.35750844758205236,0,0,3
114,Wnt signaling WP428,0.0867835776773305,1.6012061711079943,3.9138888856906373,"['INVS', 'GSK3B', 'PRICKLE2', 'PRKCA', 'PRICKLE1', 'LRP6', 'PPP3R2', 'PPP3CC', 'PLCB4', 'DAAM1', 'APC', 'WIF1', 'MAP3K7']",0.35950337066634824,0,0,13
115,mBDNF and proBDNF regulation of GABA neurotransmission WP4829,0.08722128191272162,2.129260829888883,5.193920675156182,"['ROCK1', 'PTEN', 'PIK3R3', 'PIK3CB', 'JAK2', 'GABRG3']",0.35950337066634824,0,0,6
116,Wnt signaling pathway and pluripotency WP399,0.08894392622365047,1.6299105486623522,3.9439746650946153,"['MAP2K4', 'GSK3B', 'PRKCI', 'CREBBP', 'APC', 'PPP2R5E', 'PRKCE', 'EP300', 'PRKCA', 'PPP2R5C', 'MAP3K7', 'LRP6']",0.36105706011342875,0,0,12
117,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.08991105132123994,1.5087412336684498,3.634458682642848,"['MAP2K3', 'SMAD2', 'MAP2K4', 'GSK3B', 'TUSC3', 'EED', 'NUBPL', 'PIK3R3', 'PIK3CB', 'NR2C2', 'LRP6', 'ZEB2', 'PAK1', 'MAPK1', 'SOS1', 'SOS2']",0.36105706011342875,0,0,16
118,IL-3 signaling pathway WP286,0.09126779818748687,1.9575292026409346,4.6862412402736595,"['STAT5B', 'MAPK1', 'FYN', 'ENPP3', 'GAB2', 'JAK2', 'SOS1']",0.36105706011342875,0,0,7
119,Splicing factor NOVA regulated synaptic proteins WP4148,0.09126779818748687,1.9575292026409346,4.6862412402736595,"['PLCB4', 'CASK', 'GRIK2', 'STX2', 'NEO1', 'GRIN2B', 'CLASP1']",0.36105706011342875,0,0,7
120,Phosphodiesterases in neuronal function WP4222,0.09293029817265465,1.8459818308874913,4.385878475073391,"['GUCY1A2', 'GUCY1A1', 'GRIN2A', 'ADCY9', 'DRD1', 'PDE7A', 'GRIN2B', 'ADCY5']",0.36105706011342875,0,0,8
121,The Overlap Between Signal Transduction Pathways that Contribute to a Range of LMNA Laminopathies WP4879,0.09293029817265465,1.8459818308874913,4.385878475073391,"['RB1', 'SMAD2', 'GSK3B', 'KAT2B', 'CREBBP', 'APC', 'HDAC1', 'DICER1']",0.36105706011342875,0,0,8
122,Wnt Signaling Pathway WP363,0.09293029817265465,1.8459818308874913,4.385878475073391,"['GSK3B', 'APC', 'MAPK1', 'PRKCA', 'TCF4', 'MAP3K7', 'CSNK1G1', 'LRP6']",0.36105706011342875,0,0,8
123,VEGFA-VEGFR2 Signaling Pathway WP3888,0.09771119646311643,1.251987281399046,2.9117958056770172,"['GSK3B', 'PRKAA1', 'ROCK1', 'HDAC1', 'USP10', 'FAF1', 'GIGYF2', 'SLC8A1', 'FOXO1', 'ACACA', 'PAK1', 'MKNK1', 'MYO6', 'FAM120A', 'ABL1', 'MAPK1', 'FYN', 'LRRFIP2', 'MAP3K5', 'MAP2K3', 'ACOT9', 'MAP2K4', 'PTPN1', 'RBM39', 'MEF2C', 'PRKCI', 'CREBBP', 'FBXW11', 'PRKCE', 'TRPC1', 'RPS6', 'EIF2AK3', 'ARNT', 'ADAM10', 'PDE4DIP', 'PRKCA', 'PTK2', 'ITCH', 'RPS6KB1', 'EWSR1', 'NUMB', 'SPIRE1', 'PTPN9', 'ATF6', 'SLC25A11']",0.37243804500918815,0,0,45
124,p38 MAPK Signaling Pathway WP400,0.09821678402141037,2.0502442428471737,4.757752015715505,"['MAP2K4', 'MAP3K1', 'MKNK1', 'MAP3K9', 'MAP3K7', 'MAP3K5']",0.37243804500918815,0,0,6
125,TNF related weak inducer of apoptosis (TWEAK) Signaling Pathway WP2036,0.09821678402141037,2.0502442428471737,4.757752015715505,"['GSK3B', 'CHUK', 'HDAC1', 'TRAF3', 'MAPK1', 'MAP3K7']",0.37243804500918815,0,0,6
126,Interferon type I signaling pathways WP585,0.10203811788541595,1.800821530227881,4.110210963195255,"['RPTOR', 'MAP2K3', 'MAP3K1', 'RPS6KB1', 'RPS6', 'FYN', 'GAB2', 'PIAS1']",0.3838576815689457,0,0,8
127,Resistin as a regulator of inflammation WP4481,0.10449674606783729,2.196154612472604,4.960233371816421,"['PLCB4', 'CHUK', 'MAPK1', 'PLCE1', 'PIK3CB']",0.3900114774500384,0,0,5
128,ESC Pluripotency Pathways WP3931,0.1061877389897254,1.5392706872370268,3.4518862906488392,"['MAP2K3', 'GSK3B', 'BMPR2', 'PTEN', 'LIFR', 'EGFR', 'LRP6', 'FGF14', 'APC', 'SELENOP', 'MAPK1', 'SOS1', 'BMPR1A']",0.3932264709463269,0,0,13
129,Mitochondrial Gene Expression WP391,0.10849872543510063,2.4590940766550524,5.461689387886028,"['MYEF2', 'NRF1', 'TFB1M', 'PPARGC1A']",0.39598054874350247,0,0,4
130,exRNA mechanism of action and biogenesis WP2805,0.11027306420705132,4.60821155184412,10.160164495207225,"['DROSHA', 'DICER1']",0.39598054874350247,0,0,2
131,miRNA Biogenesis WP2338,0.11027306420705132,4.60821155184412,10.160164495207225,"['DROSHA', 'DICER1']",0.39598054874350247,0,0,2
132,Somatroph axis (GH) and its relationship to dietary restriction and aging WP4186,0.11027306420705132,4.60821155184412,10.160164495207225,"['PTEN', 'FOXO1']",0.39598054874350247,0,0,2
133,Head and Neck Squamous Cell Carcinoma WP4674,0.11652039158625592,1.619461529962064,3.481338614563322,"['RB1', 'RPTOR', 'PRKAA1', 'TRAF3', 'RPS6', 'PTEN', 'NUMB', 'PIK3CB', 'CSMD3', 'EGFR']",0.4150156035031984,0,0,10
134,Focal Adhesion WP306,0.11732508622242316,1.3668626710900098,2.9289224655341486,"['GSK3B', 'PPP1R12A', 'ROCK1', 'PTEN', 'PIK3R3', 'PRKCA', 'PARVA', 'VEGFD', 'PIK3CB', 'PTK2', 'EGFR', 'ARHGAP35', 'DIAPH1', 'PAK1', 'PDGFD', 'ITGA8', 'MAPK1', 'FYN', 'PAK3', 'PPP1R12B', 'SOS1']",0.4150156035031984,0,0,21
135,PI3K-Akt signaling pathway WP4172,0.11945490849155369,1.2957446808510638,2.753219436156056,"['GSK3B', 'PRKAA1', 'PHLPP1', 'PTEN', 'PIK3R3', 'PIK3CB', 'EGFR', 'RPTOR', 'PPP2R5E', 'PDGFD', 'MAPK1', 'JAK2', 'CHUK', 'RPS6', 'PRKCA', 'VEGFD', 'PPP2R5C', 'PTK2', 'EPOR', 'EFNA3', 'FGF14', 'RPS6KB1', 'GNB2', 'PPP2R2D', 'ITGA8', 'PKN2', 'SGK1', 'SOS1', 'SOS2']",0.4194194564814552,0,0,29
136,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.12288436938749549,1.7939944134078212,3.7611298326205,"['PPP1R16B', 'PPP1R13B', 'PPP1R12A', 'EIF2AK3', 'PPP1R9A', 'PPP1R12B', 'ATF6']",0.42828816977700634,0,0,7
137,Thermogenesis WP4321,0.12797344847820613,1.4819230169861306,3.046733649171771,"['MAP2K3', 'PRKAA1', 'RPS6', 'ACSL4', 'ADCY5', 'RPTOR', 'ADCY9', 'RPS6KB1', 'RPS6KA2', 'SOS1', 'PPARGC1A', 'SOS2', 'MAP3K5']",0.44276944947934094,0,0,13
138,T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection WP3863,0.13452047968849168,1.7453759625547336,3.501291947182646,"['GSK3B', 'PAK1', 'CHUK', 'FYN', 'SOS1', 'MAP3K7', 'PDK1']",0.4538093609519491,0,0,7
139,Hedgehog Signaling Pathway WP4249,0.1352926261633076,1.84480111653873,3.690183797760036,"['CSNK1G3', 'GRK3', 'SMURF2', 'SUFU', 'CDON', 'CSNK1G1']",0.4538093609519491,0,0,6
140,Endometrial cancer WP4155,0.13898933761352986,1.5971490048413126,3.151746856310204,"['GSK3B', 'APC', 'PTEN', 'PIK3R3', 'MAPK1', 'PIK3CB', 'SOS1', 'SOS2', 'EGFR']",0.4538093609519491,0,0,9
141,Angiogenesis WP1539,0.14384449358255522,2.169460955113753,4.206633536718383,"['CREBBP', 'ARNT', 'MAPK1', 'PTK2']",0.4538093609519491,0,0,4
142,Heart Development WP1591,0.14384449358255522,2.169460955113753,4.206633536718383,"['MEF2C', 'BMPR2', 'MAPK1', 'BMPR1A']",0.4538093609519491,0,0,4
143,IL-7 signaling pathway WP205,0.14384449358255522,2.169460955113753,4.206633536718383,"['GSK3B', 'STAT5B', 'MAPK1', 'FYN']",0.4538093609519491,0,0,4
144,NRF2-ARE regulation WP4357,0.14384449358255522,2.169460955113753,4.206633536718383,"['GSK3B', 'YES1', 'PRKCA', 'FYN']",0.4538093609519491,0,0,4
145,TLR4 Signaling and Tolerance WP3851,0.14384449358255522,2.169460955113753,4.206633536718383,"['TBK1', 'CHUK', 'TRAF3', 'MAP3K7']",0.4538093609519491,0,0,4
146,Toll-like Receptor Signaling related to MyD88 WP3858,0.14384449358255522,2.169460955113753,4.206633536718383,"['TBK1', 'CHUK', 'TRAF3', 'MAPK1']",0.4538093609519491,0,0,4
147,Aspirin and miRNAs WP4707,0.14466711593211493,3.6862908837856647,7.126779626149693,"['PPARA', 'PDK1']",0.4538093609519491,0,0,2
148,DDX1 as a regulatory component of the Drosha microprocessor WP2942,0.14466711593211493,3.6862908837856647,7.126779626149693,"['DROSHA', 'ATM']",0.4538093609519491,0,0,2
149,Insulin signaling in adipocytes (diabetic condition) WP3635,0.14466711593211493,3.6862908837856647,7.126779626149693,"['RPS6KB1', 'RPS6']",0.4538093609519491,0,0,2
150,Insulin signaling in adipocytes (normal condition) WP3634,0.14466711593211493,3.6862908837856647,7.126779626149693,"['RPS6KB1', 'RPS6']",0.4538093609519491,0,0,2
151,RANKL/RANK signaling pathway WP2018,0.14667625302719814,1.6993163775360187,3.261884486145756,"['CHUK', 'TRAF3', 'MAPK1', 'GAB2', 'MAP3K7', 'PAPSS2', 'PTK2']",0.4538093609519491,0,0,7
152,Structural Pathway of Interleukin 1 (IL-1) WP2637,0.14667625302719814,1.6993163775360187,3.261884486145756,"['MAP2K3', 'MAP2K4', 'MAP3K1', 'CHUK', 'MKNK1', 'MAPK1', 'MAP3K7']",0.4538093609519491,0,0,7
153,Autophagy WP4923,0.14879901938498577,1.9211994421199443,3.660189921424334,"['RPTOR', 'UVRAG', 'PRKAA1', 'AMBRA1', 'ATG5']",0.4538093609519491,0,0,5
154,Initiation of transcription and translation elongation at the HIV-1 LTR WP3414,0.14879901938498577,1.9211994421199443,3.660189921424334,"['CREBBP', 'PPP3CC', 'PPP3R2', 'HDAC1', 'EP300']",0.4538093609519491,0,0,5
155,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.14935497955380606,1.5668953687821612,2.979340910538674,"['RB1', 'MAP2K3', 'GNA13', 'RPS6KB1', 'GNAQ', 'RPS6', 'GNAI3', 'MAPK1', 'JAK2']",0.4538093609519491,0,0,9
156,Toll-like Receptor Signaling Pathway WP75,0.14935497955380606,1.5668953687821612,2.979340910538674,"['MAP2K3', 'MAP2K4', 'TBK1', 'CHUK', 'TRAF3', 'PIK3R3', 'MAPK1', 'PIK3CB', 'MAP3K7']",0.4538093609519491,0,0,9
157,Extracellular vesicles in the crosstalk of cardiac cells WP4300,0.1514015150184747,2.5139908837680425,4.745962097488363,"['PTEN', 'SORBS2', 'EGFR']",0.4542045450554241,0,0,3
158,Transcription co-factors SKI and SKIL protein partners WP4533,0.1514015150184747,2.5139908837680425,4.745962097488363,"['LATS1', 'HDAC1', 'MERTK']",0.4542045450554241,0,0,3
159,Apoptosis WP254,0.1600925913036547,1.5377622377622377,2.8171849336510566,"['HELLS', 'MAP2K4', 'MAP3K1', 'CHUK', 'CRADD', 'CASP6', 'TRAF3', 'IRF2', 'CASP2']",0.474274301737077,0,0,9
160,Melanoma WP4685,0.1600925913036547,1.5377622377622377,2.8171849336510566,"['RB1', 'GRIN2A', 'PAK1', 'PTEN', 'PIK3R3', 'MAPK1', 'PIK3CB', 'SOS1', 'SOS2']",0.474274301737077,0,0,9
161,Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4) WP2817,0.1629991962963654,2.048780487804878,3.716508310885677,"['PTPN1', 'CHUK', 'JAK2', 'EGFR']",0.4767706697390628,0,0,4
162,Wnt/beta-catenin signaling pathway in leukemia WP3658,0.1629991962963654,2.048780487804878,3.716508310885677,"['GSK3B', 'APC', 'WIF1', 'LRP6']",0.4767706697390628,0,0,4
163,MicroRNAs in cardiomyocyte hypertrophy WP1544,0.16395278305372835,1.488295446849816,2.6911012997605233,"['MAP2K3', 'GSK3B', 'MAP2K4', 'MYEF2', 'CHUK', 'ROCK1', 'PIK3R3', 'MAPK1', 'PIK3CB', 'LRP6']",0.4767706697390628,0,0,10
164,Oncostatin M Signaling Pathway WP2374,0.16638203702488935,1.5702157396256151,2.816132792247492,"['STAT5B', 'PRKCE', 'RPS6', 'MAPK1', 'PRKCA', 'LIFR', 'JAK2', 'SOS1']",0.4808846679865704,0,0,8
165,Genotoxicity pathway WP4286,0.1724593542629217,1.6141061452513967,2.836942788371704,"['IKBIP', 'TIGAR', 'DAAM1', 'BRMS1L', 'LRRFIP2', 'PPM1D', 'PHLDA3']",0.49542869042802956,0,0,7
166,Canonical and non-canonical TGF-B signaling WP3874,0.1762366256077147,2.304317548746518,4.000128716030935,"['SMAD2', 'BMPR2', 'BMPR1A']",0.5002165301680046,0,0,3
167,MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement WP4560,0.1762366256077147,2.304317548746518,4.000128716030935,"['MAPK1', 'LPP', 'PTK2']",0.5002165301680046,0,0,3
168,Cell Differentiation - Index WP2029,0.1808656132056238,3.071677105080028,5.252570896666915,"['MEF2A', 'MEF2C']",0.504295886232151,0,0,2
169,Leptin and adiponectin WP3934,0.1808656132056238,3.071677105080028,5.252570896666915,"['PRKAA1', 'ACACA']",0.504295886232151,0,0,2
170,SRF and miRs in Smooth Muscle Differentiation and Proliferation WP1991,0.1808656132056238,3.071677105080028,5.252570896666915,"['MEF2A', 'MEF2C']",0.504295886232151,0,0,2
171,BDNF-TrkB Signaling WP3676,0.1820338619545221,1.7731466580838966,3.020666250377255,"['RPS6KB1', 'MKNK1', 'MAPK1', 'GAB2', 'SOS1']",0.5045850910318332,0,0,5
172,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.1860374877195876,1.5746184766316937,2.6482045002467043,"['HELLS', 'RPS6KB1', 'HDAC1', 'CUL1', 'ABL1', 'MAPK1', 'PTK2']",0.5126847045295612,0,0,7
173,IL-18 signaling pathway WP4754,0.19766066653225053,1.2463469439886392,2.0205820576272706,"['MEF2A', 'ZNF143', 'GSK3B', 'PRKAA1', 'USP5', 'CHUK', 'FBXW7', 'PTEN', 'PRKCA', 'GRIN2B', 'IL17RC', 'TMEM165', 'RPTOR', 'ALS2', 'RPS6KB1', 'NFKBIZ', 'LONP2', 'MAPK1', 'TRPM7', 'KIFC3', 'LRRFIP1', 'MAP3K7']",0.5415673753542587,0,0,22
174,SREBF and miR33 in cholesterol and lipid homeostasis WP2011,0.20208787266810152,2.1269016498821514,3.4010277471051404,"['PRKAA1', 'PPARA', 'PPARGC1A']",0.550515239337242,0,0,3
175,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.20414541308048997,1.4756673654786863,2.344721418703502,"['STAT5B', 'PAK1', 'CHUK', 'MAPK1', 'SOS1', 'FOXO1', 'EGFR', 'PTK2']",0.5529424331437272,0,0,8
176,Primary focal segmental glomerulosclerosis (FSGS) WP2572,0.21743590924493386,1.446623093681917,2.2073314995604174,"['SMARCAL1', 'PLCE1', 'FYN', 'PARVA', 'PTK2', 'CD2AP', 'LRP6', 'LIMS1']",0.5829782870557508,0,0,8
177,Parkinson's disease pathway WP2371,0.21769442364740063,1.6462442717672843,2.509967608169398,"['PRKN', 'ATXN2', 'CASP6', 'CASP2', 'UBE2G1']",0.5829782870557508,0,0,5
178,Signal transduction through IL1R WP4496,0.22516868329400289,1.7556993529118965,2.6175817410796145,"['MAP2K3', 'MAP3K1', 'CHUK', 'MAP3K7']",0.5840528540268924,0,0,4
179,ATM Signaling Network in Development and Disease  WP3878,0.22520306361869055,1.5366364270760642,2.290745023697377,"['PRKAA1', 'TRIM28', 'CHEK1', 'ATM', 'PPM1D', 'MAP3K5']",0.5840528540268924,0,0,6
180,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.22752572701490906,1.1943889892364081,1.7682832971162994,"['GSK3B', 'PRKAA1', 'PHLPP1', 'PTEN', 'PIK3CB', 'EGFR', 'FOXO1', 'ACACA', 'RPTOR', 'PPP2R5E', 'PDGFD', 'MAPK1', 'JAK2', 'PPARGC1A', 'RPS6', 'VEGFD', 'PPP2R5C', 'PTK2', 'EPOR', 'EFNA3', 'FGF14', 'RPS6KB1', 'GNB2', 'PPP2R2D', 'ITGA8', 'SOS1']",0.5840528540268924,0,0,26
181,Apoptosis Modulation by HSP70 WP384,0.22874035812780286,1.9748308794269798,2.9132067775911357,"['MAP3K1', 'CASP6', 'CASP2']",0.5840528540268924,0,0,3
182,Constitutive Androstane Receptor Pathway WP2875,0.22874035812780286,1.9748308794269798,2.9132067775911357,"['NCOA6', 'PPARGC1A', 'FOXO1']",0.5840528540268924,0,0,3
183,Ebstein-Barr virus LMP1 signaling WP262,0.22874035812780286,1.9748308794269798,2.9132067775911357,"['CHUK', 'MAPK1', 'MAP3K7']",0.5840528540268924,0,0,3
184,Nuclear Receptors in Lipid Metabolism and Toxicity WP299,0.22874035812780286,1.9748308794269798,2.9132067775911357,"['ABCD3', 'RARB', 'PPARA']",0.5840528540268924,0,0,3
185,G1 to S cell cycle control WP45,0.22918529714979324,1.4669248349415946,2.161109525461883,"['RB1', 'ORC5', 'PRIM2', 'TFDP2', 'ORC2', 'ATM', 'MNAT1']",0.5840528540268924,0,0,7
186,IL-1 signaling pathway WP195,0.22918529714979324,1.4669248349415946,2.161109525461883,"['MAP2K3', 'MAP3K2', 'MAP2K4', 'MAP3K1', 'CHUK', 'MAPK1', 'MAP3K7']",0.5840528540268924,0,0,7
187,Bladder cancer WP2828,0.2362782000992028,1.589356995142596,2.2930374209589197,"['RB1', 'DAPK1', 'DAPK2', 'MAPK1', 'EGFR']",0.5957226959947985,0,0,5
188,Signaling of Hepatocyte Growth Factor Receptor WP313,0.2362782000992028,1.589356995142596,2.2930374209589197,"['PAK1', 'PTEN', 'MAPK1', 'SOS1', 'PTK2']",0.5957226959947985,0,0,5
189,Myometrial relaxation and contraction pathways WP289,0.2412553296025351,1.2581077630234934,1.7889027330005922,"['ATF1', 'GUCY1A1', 'PRKCE', 'ITPR2', 'PRKCA', 'SLC8A1', 'ADCY5', 'ADCY9', 'GRK5', 'PRKAR2B', 'GRK4', 'PRKAR2A', 'GNB2', 'GNAQ', 'RGS9']",0.6038426906330997,0,0,15
190,Lipid Metabolism Pathway WP3965,0.24710903620372074,1.6757681343047197,2.3425991706552343,"['PRKAA1', 'PRKAR2B', 'PRKAR2A', 'ACACA']",0.6038426906330997,0,0,4
191,Nanoparticle-mediated activation of receptor signaling WP2643,0.24710903620372074,1.6757681343047197,2.3425991706552343,"['MAPK1', 'SOS1', 'EGFR', 'PTK2']",0.6038426906330997,0,0,4
192,Adipogenesis WP236,0.2503039933012319,1.2870064047196101,1.782605706992596,"['RB1', 'MEF2A', 'STAT5B', 'MEF2C', 'RBL1', 'NCOR1', 'HMGA1', 'RORA', 'LIFR', 'PPARA', 'PPARGC1A', 'FOXO1']",0.6038426906330997,0,0,12
193,mRNA Processing WP411,0.2509201613637469,1.246678560583055,1.723683300695138,"['SRPK2', 'RBM39', 'RNGTT', 'CPSF1', 'FUS', 'SFSWAP', 'CELF2', 'DICER1', 'PTBP2', 'PRPF18', 'DHX15', 'SRSF4', 'SREK1', 'CLASRP', 'RBM5']",0.6038426906330997,0,0,15
194,Hippo-Yap signaling pathway WP4537,0.2559897255880304,1.8430362116991643,2.5113542609239032,"['LATS1', 'NF2', 'MAP4K4']",0.6038426906330997,0,0,3
195,miRNAs involvement in the immune response in sepsis WP4329,0.2559897255880304,1.8430362116991643,2.5113542609239032,"['CHUK', 'TRAF3', 'MAP3K7']",0.6038426906330997,0,0,3
196,"Relationship between inflammation, COX-2 and EGFR WP4483",0.2559897255880304,1.8430362116991643,2.5113542609239032,"['MAPK1', 'PIK3CB', 'EGFR']",0.6038426906330997,0,0,3
197,Vitamin D in inflammatory diseases WP4482,0.2559897255880304,1.8430362116991643,2.5113542609239032,"['MAP2K3', 'MAP3K1', 'CHUK']",0.6038426906330997,0,0,3
198,Cancer immunotherapy by CTLA4 blockade WP4582,0.25605987514188405,2.303409881697982,3.1380365733122604,"['PIK3R3', 'PIK3CB']",0.6038426906330997,0,0,2
199,"GPCRs, Class C Metabotropic glutamate, pheromone WP501",0.25605987514188405,2.303409881697982,3.1380365733122604,"['GPRC5B', 'GRM8']",0.6038426906330997,0,0,2
200,MFAP5-mediated ovarian cancer cell motility and invasiveness WP3301,0.25605987514188405,2.303409881697982,3.1380365733122604,"['MAPK1', 'PTK2']",0.6038426906330997,0,0,2
201,Osteopontin Signaling WP1434,0.25605987514188405,2.303409881697982,3.1380365733122604,"['CHUK', 'MAPK1']",0.6038426906330997,0,0,2
202,Senescence and Autophagy in Cancer WP615,0.26804830232104937,1.2987512197045112,1.7099203775666907,"['RB1', 'MAP2K3', 'UVRAG', 'GSK3B', 'ATG10', 'HMGA1', 'PTEN', 'MAPK1', 'AMBRA1', 'ATG5']",0.6230986050523482,0,0,10
203,Intraflagellar transport proteins binding to dynein WP4532,0.2694835739150451,1.602787456445993,2.101651591386838,"['IFT140', 'WDR60', 'DYNLT3', 'DYNC1I1']",0.6230986050523482,0,0,4
204,Overview of leukocyte-intrinsic Hippo pathway functions WP4542,0.2694835739150451,1.602787456445993,2.101651591386838,"['VMP1', 'LATS1', 'PRDM1', 'FOXO1']",0.6230986050523482,0,0,4
205,Oxidation by Cytochrome P450 WP43,0.2694835739150451,1.602787456445993,2.101651591386838,"['CYB5B', 'CYP2U1', 'CYP4V2', 'CYP2C18']",0.6230986050523482,0,0,4
206,NO/cGMP/PKG mediated Neuroprotection WP4008,0.27463122493135045,1.486592882530256,1.9211627546819874,"['GUCY1A2', 'GRIN2A', 'GUCY1A1', 'AKAP9', 'GRIN2B']",0.6258908577712474,0,0,5
207,Notch Signaling WP268,0.27463122493135045,1.486592882530256,1.9211627546819874,"['KAT2B', 'CREBBP', 'ADAM17', 'HDAC1', 'NUMB']",0.6258908577712474,0,0,5
208,DNA damage response WP707,0.275309126130488,1.3729793177225722,1.770952088031417,"['RB1', 'PIDD1', 'CHEK1', 'TLK2', 'ABL1', 'TLK1', 'ATM']",0.6258908577712474,0,0,7
209,Prader-Willi and Angelman Syndrome WP3998,0.27597297315230107,1.4181115465135004,1.8257510309549903,"['RB1', 'CYFIP1', 'SLC45A2', 'HERC2', 'GNRH1', 'GABRG3']",0.6258908577712474,0,0,6
210,Serotonin Receptor 4/6/7 and NR3C Signaling WP734,0.28364428709510886,1.7277158774373258,2.176981328589164,"['ATF1', 'MAPK1', 'HTR4']",0.6402256765861029,0,0,3
211,Host-pathogen interaction of human coronaviruses - interferon induction WP4880,0.2921910216780212,1.5358885017421602,1.8896765887951494,"['TBK1', 'CHUK', 'TRAF3', 'MAP3K7']",0.6457634032441291,0,0,4
212,Renin-angiotensin-aldosterone system (RAAS) WP4756,0.2921910216780212,1.5358885017421602,1.8896765887951494,"['ATF1', 'CAMK1D', 'GNAQ', 'ITPR2']",0.6457634032441291,0,0,4
213,Bone morphogenic protein (BMP) signaling and regulation WP1425,0.2940223336348895,2.0473208072373,2.5061244784028167,"['BMPR2', 'BMPR1A']",0.6457634032441291,0,0,2
214,Neuroinflammation WP4919,0.2940223336348895,2.0473208072373,2.5061244784028167,"['CHUK', 'ASCC1']",0.6457634032441291,0,0,2
215,RAS and bradykinin pathways in COVID-19 WP4969,0.2940223336348895,2.0473208072373,2.5061244784028167,"['ROCK1', 'MAPK1']",0.6457634032441291,0,0,2
216,Nephrotic syndrome WP4758,0.2942719305922613,1.4400278940027893,1.7615155687743587,"['SMARCAL1', 'CUBN', 'PDSS2', 'PLCE1', 'CD2AP']",0.6457634032441291,0,0,5
217,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.2983239919960033,1.2764604626143088,1.543974870356569,"['RPTOR', 'GSK3B', 'RPS6KB1', 'RPS6', 'ITPR2', 'MAPK1', 'SOS1', 'PPARGC1A', 'FOXO1']",0.6516385815949566,0,0,9
218,miRNA regulation of DNA damage response WP1530,0.3072796385425939,1.3167398244213886,1.553749136426023,"['RB1', 'PIDD1', 'CHEK1', 'TLK2', 'ABL1', 'TLK1', 'ATM']",0.6681217828861904,0,0,7
219,miRNA regulation of p53 pathway in prostate cancer WP3982,0.31152642458633906,1.625962641323939,1.8963132613766263,"['SESN3', 'PTEN', 'ATM']",0.6711978420632942,0,0,3
220,NAD Metabolism in Oncogene-Induced Senescence and Mitochondrial Dysfunction-Associated Senescence WP5046,0.31152642458633906,1.625962641323939,1.8963132613766263,"['RB1', 'PRKAA1', 'HMGA1']",0.6711978420632942,0,0,3
221,Aryl Hydrocarbon Receptor Netpath WP2586,0.3141377870260666,1.3962850259921389,1.616791352002256,"['RB1', 'EP300', 'MAPK1', 'ARNT', 'EGFR']",0.6728531188498139,0,0,5
222,Nuclear receptors WP170,0.3151337392081407,1.4743414634146341,1.7025078374883387,"['RARB', 'RORA', 'NR2C2', 'PPARA']",0.6728531188498139,0,0,4
223,Acute viral myocarditis WP4298,0.3235319291493018,1.2903072625698324,1.4560568701274947,"['GSK3B', 'CASP6', 'ABL1', 'CASP2', 'MAPK1', 'FYN', 'SOS1']",0.6818237101855374,0,0,7
224,Pathogenic Escherichia coli infection WP2272,0.3290553685361394,1.3165187917455887,1.463349143822273,"['ROCK1', 'NCK2', 'ABL1', 'PRKCA', 'FYN', 'ARHGEF2']",0.6818237101855374,0,0,6
225,Cell Differentiation - Index expanded WP2023,0.33169223716085716,1.8424495476687544,2.0332310279380508,"['MEF2A', 'MEF2C']",0.6818237101855374,0,0,2
226,Cell-type Dependent Selectivity of CCK2R Signaling WP3679,0.33169223716085716,1.8424495476687544,2.0332310279380508,"['TRPC1', 'GNAQ']",0.6818237101855374,0,0,2
227,FOXA2 pathway WP5066,0.33169223716085716,1.8424495476687544,2.0332310279380508,"['ACACA', 'FOXO1']",0.6818237101855374,0,0,2
228,ID signaling pathway WP53,0.33169223716085716,1.8424495476687544,2.0332310279380508,"['RB1', 'RBL1']",0.6818237101855374,0,0,2
229,Common Pathways Underlying Drug Addiction WP2636,0.3341673361057073,1.355115267864468,1.4853600106468583,"['GRIN2A', 'MAPK1', 'PRKCA', 'DRD1', 'GRIA3']",0.6818237101855374,0,0,5
230,Activation of NLRP3 Inflammasome by SARS-CoV-2 WP4876,0.3380122736669866,3.0702364394993045,3.3302027891678905,['TRAF3'],0.6818237101855374,0,0,1
231,Hypothetical Craniofacial Development Pathway WP3655,0.3380122736669866,3.0702364394993045,3.3302027891678905,['ARHGAP29'],0.6818237101855374,0,0,1
232,CAMKK2  Pathway WP4874,0.338218469268225,1.417528812650764,1.5366908682460647,"['RPTOR', 'EP300', 'MAPK1', 'ARHGEF7']",0.6818237101855374,0,0,4
233,Fatty Acid Biosynthesis WP357,0.3394734084468077,1.5355153203342617,1.6589088104549727,"['PC', 'ACSL4', 'ACACA']",0.6818237101855374,0,0,3
234,Gastric Cancer Network 1 WP2361,0.3394734084468077,1.5355153203342617,1.6589088104549727,"['APC', 'CEP192', 'GATD3B']",0.6818237101855374,0,0,3
235,Hypothesized Pathways in Pathogenesis of Cardiovascular Disease WP3668,0.3394734084468077,1.5355153203342617,1.6589088104549727,"['SMAD2', 'MAPK1', 'NR2C2']",0.6818237101855374,0,0,3
236,Unfolded protein response WP4925,0.3394734084468077,1.5355153203342617,1.6589088104549727,"['EIF2AK3', 'CASP2', 'ATF6']",0.6818237101855374,0,0,3
237,Regulation of toll-like receptor signaling pathway WP1449,0.34652385886130566,1.1970045350031355,1.268589722570869,"['MAP2K3', 'MAP2K4', 'TBK1', 'CHUK', 'TRAF3', 'PIK3R3', 'MAPK1', 'PIK3CB', 'ZMYND11', 'MAP3K7']",0.6930477177226113,0,0,10
238,TGF-beta Receptor Signaling WP560,0.35430104180291516,1.3162980673440925,1.3658018350438228,"['SMAD2', 'ZEB2', 'CREBBP', 'ZFYVE9', 'EP300']",0.7056247639268143,0,0,5
239,Alpha 6 Beta 4 signaling pathway WP244,0.36135692464842034,1.364924506387921,1.3893417748698673,"['MAPK1', 'PRKCA', 'SOS1', 'PTK2']",0.7111268641032701,0,0,4
240,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.36514347957948945,1.2564867093827317,1.265866266949383,"['PLCB4', 'PRKCE', 'SP3', 'PLCE1', 'MAPK1', 'PRKCA']",0.7111268641032701,0,0,6
241,Novel intracellular components of RIG-I-like receptor (RLR) pathway WP3865,0.36514347957948945,1.2564867093827317,1.265866266949383,"['TBK1', 'MAP3K1', 'CHUK', 'TRAF3', 'MAP3K7', 'ATG5']",0.7111268641032701,0,0,6
242,p53 transcriptional gene network WP4963,0.36514347957948945,1.2564867093827317,1.265866266949383,"['PIDD1', 'TIGAR', 'DRAM1', 'PTEN', 'ERCC5', 'ACAD11']",0.7111268641032701,0,0,6
243,Airway smooth muscle cell contraction WP4962,0.368762643048914,1.6748276080217626,1.6708115149195082,"['ROCK1', 'GNAQ']",0.7111268641032701,0,0,2
244,Major receptors targeted by epinephrine and norepinephrine WP4589,0.368762643048914,1.6748276080217626,1.6708115149195082,"['ADCY9', 'ADCY5']",0.7111268641032701,0,0,2
245,miRNAs involved in DNA damage response WP1545,0.368762643048914,1.6748276080217626,1.6708115149195082,"['ABL1', 'ATM']",0.7111268641032701,0,0,2
246,B Cell Receptor Signaling Pathway WP23,0.36906584086372246,1.184835164835165,1.1810202566632146,"['GSK3B', 'MEF2C', 'CHUK', 'MAPK1', 'FYN', 'GAB2', 'SOS1', 'MAP3K7', 'FOXO1']",0.7111268641032701,0,0,9
247,Regulatory circuits of the STAT3 signaling pathway WP4538,0.3729640917234711,1.2169943080004215,1.2002887887639306,"['RPTOR', 'CREBBP', 'TRIM28', 'MAPK1', 'LIFR', 'JAK2', 'EGFR']",0.7157286618499,0,0,7
248,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.39465441142397434,1.2449583474688077,1.1574935557809274,"['RB1', 'MAP2K3', 'MAP2K4', 'EGFR', 'MAP3K5']",0.7315924816312755,0,0,5
249,Cell migration and invasion through p75NTR WP4561,0.39498719824741507,1.3817548746518107,1.2835147617075051,"['TIAM1', 'PAK1', 'EFNA3']",0.7315924816312755,0,0,3
250,Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome WP4320,0.39498719824741507,1.3817548746518107,1.2835147617075051,"['RB1', 'HDAC1', 'MTA3']",0.7315924816312755,0,0,3
251,MTHFR deficiency WP4288,0.39498719824741507,1.3817548746518107,1.2835147617075051,"['GRIN2A', 'SGMS1', 'EHMT1']",0.7315924816312755,0,0,3
252,Sphingolipid Metabolism (integrated pathway) WP4726,0.39498719824741507,1.3817548746518107,1.2835147617075051,"['CERS5', 'CERS6', 'SGMS1']",0.7315924816312755,0,0,3
253,ACE Inhibitor Pathway WP554,0.4028899462875358,2.3025034770514603,2.0931871236307167,['NR3C2'],0.7315924816312755,0,0,1
254,FOXP3 in COVID-19 WP5063,0.4028899462875358,2.3025034770514603,2.0931871236307167,['STAT5B'],0.7315924816312755,0,0,1
255,Mitochondrial fatty acid synthesis pathway WP4317,0.4028899462875358,2.3025034770514603,2.0931871236307167,['ACACA'],0.7315924816312755,0,0,1
256,Tgif disruption of Shh signaling WP3674,0.4028899462875358,2.3025034770514603,2.0931871236307167,['SMAD2'],0.7315924816312755,0,0,1
257,Deregulation of Rab and Rab Effector Genes in Bladder Cancer WP2291,0.4049894870791105,1.535142658315936,1.3876064990343453,"['MYRIP', 'SYTL2']",0.7315924816312755,0,0,2
258,ERK Pathway in Huntington's Disease WP3853,0.4049894870791105,1.535142658315936,1.3876064990343453,"['MAPK1', 'EGFR']",0.7315924816312755,0,0,2
259,IL-9 signaling pathway WP22,0.4049894870791105,1.535142658315936,1.3876064990343453,"['STAT5B', 'MAPK1']",0.7315924816312755,0,0,2
260,TGF-B Signaling in Thyroid Cells for Epithelial-Mesenchymal Transition WP3859,0.4049894870791105,1.535142658315936,1.3876064990343453,"['SMAD2', 'MAPK1']",0.7315924816312755,0,0,2
261,TP53 network WP1742,0.4049894870791105,1.535142658315936,1.3876064990343453,"['ABL1', 'ATM']",0.7315924816312755,0,0,2
262,Type II diabetes mellitus WP1584,0.4049894870791105,1.535142658315936,1.3876064990343453,"['MAPK1', 'PHKA2']",0.7315924816312755,0,0,2
263,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.406165191856544,1.172562214321991,1.056473074124148,"['PRKN', 'PSMD14', 'FBXW7', 'CUL1', 'PSMD1', 'CASK', 'UBE2G1']",0.7315924816312755,0,0,7
264,Oxidative Damage WP3941,0.40746923027564713,1.270599543433858,1.1407313832654074,"['MAP2K4', 'MAP3K1', 'TRAF3', 'MAP3K9']",0.7315924816312755,0,0,4
265,Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway WP4577,0.4147674483134039,1.2121045291051897,1.0666971744751343,"['RPTOR', 'PRKAA1', 'ATG10', 'ACACA', 'ATG5']",0.7418859264171829,0,0,5
266,FGFR3 signaling in chondrocyte proliferation and terminal differentiation WP4767,0.4223044320655882,1.315857540787903,1.1343071258488566,"['RBL1', 'MAPK1', 'ATG5']",0.7525274466131158,0,0,3
267,DNA IR-damage and cellular response via ATR WP4016,0.42506851184759253,1.1338386281782509,0.9700045234213527,"['SMARCAL1', 'BRIP1', 'HERC2', 'TRIM28', 'UIMC1', 'CHEK1', 'ATM', 'PPM1D']",0.7546160097968496,0,0,8
268,DNA Replication WP466,0.430294693217203,1.2281533101045297,1.0356832296798875,"['ORC5', 'PRIM2', 'POLA1', 'ORC2']",0.758214440836261,0,0,4
269,Target Of Rapamycin (TOR) Signaling WP1471,0.430294693217203,1.2281533101045297,1.0356832296798875,"['RPTOR', 'PRKAA1', 'RPS6KB1', 'PRKCA']",0.758214440836261,0,0,4
270,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.43477180523409,1.180935521939706,0.9836413140267761,"['SMAD2', 'ZEB2', 'CREBBP', 'ZFYVE9', 'EP300']",0.7632660580776246,0,0,5
271,Overview of interferons-mediated signaling pathway WP4558,0.4401822220132224,1.4169477008725444,1.1626998111436009,"['PRKCA', 'JAK2']",0.7666941891300371,0,0,2
272,SARS coronavirus and innate immunity WP4912,0.4401822220132224,1.4169477008725444,1.1626998111436009,"['TBK1', 'TRAF3']",0.7666941891300371,0,0,2
273,Aryl Hydrocarbon Receptor Pathway WP2873,0.44918656934466034,1.255950873638896,1.0051587795982877,"['EP300', 'ARNT', 'EGFR']",0.7666941891300371,0,0,3
274,Sphingolipid pathway WP1422,0.44918656934466034,1.255950873638896,1.0051587795982877,"['CERS5', 'CERS6', 'SGMS1']",0.7666941891300371,0,0,3
275,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.4542883606354918,1.0731999374068757,0.8467795704895981,"['MEF2C', 'CREBBP', 'DEAF1', 'MAP2', 'PRKAR2B', 'HDAC1', 'PRKAR2A', 'SP3', 'EP300', 'RORA', 'PPARGC1A', 'CC2D1A']",0.7666941891300371,0,0,12
276,Development of pulmonary dendritic cells and macrophage subsets WP3892,0.46141329859794544,1.8418636995827538,1.424609944093942,['TCF4'],0.7666941891300371,0,0,1
277,mir-124 predicted interactions with cell cycle and differentiation  WP3595,0.46141329859794544,1.8418636995827538,1.424609944093942,['PRKAA1'],0.7666941891300371,0,0,1
278,Molybdenum cofactor (Moco) biosynthesis WP4507,0.46141329859794544,1.8418636995827538,1.424609944093942,['MARC2'],0.7666941891300371,0,0,1
279,Pilocytic astrocytoma WP2253,0.46141329859794544,1.8418636995827538,1.424609944093942,['SOS1'],0.7666941891300371,0,0,1
280,PTF1A related regulatory pathway WP4147,0.46141329859794544,1.8418636995827538,1.424609944093942,['KAT2B'],0.7666941891300371,0,0,1
281,Role of Altered Glycolysation of MUC1 in Tumour Microenvironment WP4480,0.46141329859794544,1.8418636995827538,1.424609944093942,['CHUK'],0.7666941891300371,0,0,1
282,Urea cycle and related diseases WP4571,0.46141329859794544,1.8418636995827538,1.424609944093942,['SLC25A13'],0.7666941891300371,0,0,1
283,T-cell receptor (TCR) signaling pathway WP69,0.47209818630872746,1.092735062967522,0.8201722911199636,"['PAK1', 'CHUK', 'MAPK1', 'FYN', 'GAB2', 'SOS1', 'MAP3K7']",0.7666941891300371,0,0,7
284,BMP Signaling Pathway in Eyelid Development WP3927,0.47419568557519154,1.315637737349637,0.9816436311729212,"['MAP3K1', 'EGFR']",0.7666941891300371,0,0,2
285,Globo Sphingolipid Metabolism WP1424,0.47419568557519154,1.315637737349637,0.9816436311729212,"['ST6GALNAC3', 'ST6GALNAC5']",0.7666941891300371,0,0,2
286,Kynurenine Pathway and links to Cellular Senescence WP5044,0.47419568557519154,1.315637737349637,0.9816436311729212,"['EIF2AK4', 'FOXO1']",0.7666941891300371,0,0,2
287,Pregnane X receptor pathway WP2876,0.47419568557519154,1.315637737349637,0.9816436311729212,"['PPARGC1A', 'FOXO1']",0.7666941891300371,0,0,2
288,STING pathway in Kawasaki-like disease and COVID-19 WP4961,0.47419568557519154,1.315637737349637,0.9816436311729212,"['TBK1', 'CHUK']",0.7666941891300371,0,0,2
289,Transcription factor regulation in adipogenesis WP3599,0.47419568557519154,1.315637737349637,0.9816436311729212,"['PPARGC1A', 'FOXO1']",0.7666941891300371,0,0,2
290,Urea cycle and metabolism of amino groups WP497,0.47419568557519154,1.315637737349637,0.9816436311729212,"['ARG2', 'ALDH18A1']",0.7666941891300371,0,0,2
291,Ferroptosis WP4313,0.47515816347341283,1.1512195121951219,0.856631136071192,"['PRNP', 'TFRC', 'ACSL4', 'ATG5']",0.7666941891300371,0,0,4
292,Extracellular vesicle-mediated signaling in recipient cells WP2870,0.47554449705533947,1.2012534818941505,0.8928854928434083,"['SMAD2', 'APC', 'EGFR']",0.7666941891300371,0,0,3
293,Genes controlling nephrogenesis WP4823,0.47554449705533947,1.2012534818941505,0.8928854928434083,"['NCK2', 'ITGA8', 'CD2AP']",0.7666941891300371,0,0,3
294,White fat cell differentiation WP4149,0.47554449705533947,1.2012534818941505,0.8928854928434083,"['STAT5B', 'RORA', 'FOXO1']",0.7666941891300371,0,0,3
295,Breast cancer pathway WP4262,0.4788543835640619,1.0525978576434079,0.775089620285555,"['RB1', 'GSK3B', 'RPS6KB1', 'APC', 'PTEN', 'PIK3R3', 'MAPK1', 'ATM', 'SOS1', 'SOS2', 'EGFR', 'LRP6']",0.7694134840995436,0,0,12
296,Osteoblast differentiation WP4787,0.4840721394285651,1.0626681011296395,0.7709883793573489,"['PRKCI', 'BMPR2', 'PRKCE', 'PIK3R3', 'MAPK1', 'PRKCA', 'PIK3CB', 'BMPR1A', 'LRP6']",0.77255957605771,0,0,9
297,Small cell lung cancer WP4658,0.4840721394285651,1.0626681011296395,0.7709883793573489,"['RB1', 'CHUK', 'TRAF3', 'PTEN', 'RARB', 'PIK3R3', 'PIK3CB', 'FHIT', 'PTK2']",0.77255957605771,0,0,9
298,Endochondral Ossification with Skeletal Dysplasias WP4808,0.49369057163513413,1.0963339310619646,0.7738432830716651,"['STAT5B', 'MEF2C', 'IFT88', 'SOX5', 'BMPR1A']",0.7737550434673953,0,0,5
299,Endochondral Ossification WP474,0.49369057163513413,1.0963339310619646,0.7738432830716651,"['STAT5B', 'MEF2C', 'IFT88', 'SOX5', 'BMPR1A']",0.7737550434673953,0,0,5
300,Proximal tubule transport WP4917,0.49708375733786675,1.116249604054482,0.7802548356597858,"['ATP6V0B', 'SLC20A2', 'ATP6V1H', 'SLC4A2']",0.7737550434673953,0,0,4
301,SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039,0.49708375733786675,1.116249604054482,0.7802548356597858,"['TBK1', 'AP1G1', 'TRAF3', 'EP300']",0.7737550434673953,0,0,4
302,22q11.2 copy number variation syndrome WP4657,0.4982073847390787,1.0491369390103567,0.7309744679703493,"['PRKN', 'AIFM3', 'NCOR1', 'DROSHA', 'SHOC2', 'ZDHHC8', 'LZTR1', 'TNPO1', 'EGFR']",0.7737550434673953,0,0,9
303,Pre-implantation embryo WP3527,0.5013021000026104,1.1511142061281336,0.7948977314414379,"['HMGA1', 'MTA3', 'NR3C2']",0.7737550434673953,0,0,3
304,Imatinib and Chronic Myeloid Leukemia WP3640,0.5069230459570071,1.2278357689631176,0.8341867960800433,"['ABL1', 'GAB2']",0.7737550434673953,0,0,2
305,Arrhythmogenic Right Ventricular Cardiomyopathy WP2118,0.5082387974931256,1.0625369048258093,0.7191290871302497,"['CACNB2', 'CACNG7', 'ITGA8', 'CACNA2D2', 'CACNA1C', 'SLC8A1']",0.7737550434673953,0,0,6
306,Glucocorticoid Receptor Pathway WP2880,0.5128341907611933,1.07075670591288,0.7150542202657547,"['EPB41L4B', 'TSC22D3', 'ABHD2', 'CUL1', 'CPEB4']",0.7737550434673953,0,0,5
307,Synaptic Vesicle Pathway WP2267,0.5128341907611933,1.07075670591288,0.7150542202657547,"['RIMS1', 'CACNA1B', 'STX2', 'SYN2', 'DNM2']",0.7737550434673953,0,0,5
308,Disorders of the Krebs cycle WP4236,0.5142043010384589,1.5347705146036161,1.0208290024976494,['PDHX'],0.7737550434673953,0,0,1
309,Glucuronidation WP698,0.5142043010384589,1.5347705146036161,1.0208290024976494,['PGM1'],0.7737550434673953,0,0,1
310,LDLRAD4 and what we know about it WP4904,0.5142043010384589,1.5347705146036161,1.0208290024976494,['SMAD2'],0.7737550434673953,0,0,1
311,LTF danger signal response pathway WP4478,0.5142043010384589,1.5347705146036161,1.0208290024976494,['MAPK1'],0.7737550434673953,0,0,1
312,Methionine metabolism leading to sulfur amino acids and related disorders WP4292,0.5142043010384589,1.5347705146036161,1.0208290024976494,['ADK'],0.7737550434673953,0,0,1
313,Serine Metabolism WP4688,0.5142043010384589,1.5347705146036161,1.0208290024976494,['PSPH'],0.7737550434673953,0,0,1
314,Sulfation Biotransformation Reaction WP692,0.5142043010384589,1.5347705146036161,1.0208290024976494,['PAPSS2'],0.7737550434673953,0,0,1
315,Supression of HMGB1 mediated inflammation by THBD WP4479,0.5142043010384589,1.5347705146036161,1.0208290024976494,['CHUK'],0.7737550434673953,0,0,1
316,Amino Acid metabolism WP3925,0.5203168290992782,1.0396242566228149,0.6792045811922084,"['PDHX', 'ARG2', 'PKM', 'PC', 'HIBADH', 'AUH', 'ALDH18A1']",0.7797232099223487,0,0,7
317,AMP-activated protein kinase (AMPK) signaling WP1403,0.5254273711666001,1.042410038315185,0.6708360035411609,"['RPTOR', 'PRKAA1', 'RPS6KB1', 'PIK3R3', 'PIK3CB', 'ACACA']",0.7797232099223487,0,0,6
318,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.5263954159813324,1.1049860724233984,0.7090724436502434,"['CHUK', 'ERBIN', 'PRDM1']",0.7797232099223487,0,0,3
319,Regucalcin in proximal tubule epithelial kidney cells WP4838,0.5263954159813324,1.1049860724233984,0.7090724436502434,"['SMAD2', 'MAPK1', 'MAP3K5']",0.7797232099223487,0,0,3
320,The influence of laminopathies on Wnt signaling WP4844,0.5263954159813324,1.1049860724233984,0.7090724436502434,"['GSK3B', 'APC', 'DICER1']",0.7797232099223487,0,0,3
321,Methionine De Novo and Salvage Pathway WP3580,0.5382896929001939,1.151009046624913,0.7128871227687514,"['MSRA', 'MSRB3']",0.7923891752630183,0,0,2
322,Type I interferon induction and signaling during SARS-CoV-2 infection WP4868,0.5382896929001939,1.151009046624913,0.7128871227687514,"['TBK1', 'TRAF3']",0.7923891752630183,0,0,2
323,ATR Signaling WP3875,0.5618240830245058,1.315418239618518,0.7584260873205174,['CHEK1'],0.7946384474413515,0,0,1
324,Bile acids synthesis and enterohepatic circulation  WP4389,0.5618240830245058,1.315418239618518,0.7584260873205174,['MAPK1'],0.7946384474413515,0,0,1
325,Caloric restriction and aging WP4191,0.5618240830245058,1.315418239618518,0.7584260873205174,['PPARGC1A'],0.7946384474413515,0,0,1
326,Canonical NF-KB pathway WP4562,0.5618240830245058,1.315418239618518,0.7584260873205174,['CHUK'],0.7946384474413515,0,0,1
327,Hijack of ubiquitination by SARS-CoV-2 WP4860,0.5618240830245058,1.315418239618518,0.7584260873205174,['UBA3'],0.7946384474413515,0,0,1
328,Pathogenesis of SARS-CoV-2 Mediated by nsp9-nsp10 Complex WP4884,0.5618240830245058,1.315418239618518,0.7584260873205174,['FYN'],0.7946384474413515,0,0,1
329,TFs regulate miRNAs related to cardiac hypertrophy WP1559,0.5618240830245058,1.315418239618518,0.7584260873205174,['MYEF2'],0.7946384474413515,0,0,1
330,Valproic acid pathway WP3871,0.5618240830245058,1.315418239618518,0.7584260873205174,['HDAC1'],0.7946384474413515,0,0,1
331,Retinoblastoma gene in cancer WP2446,0.5668183228548183,0.9914159862483884,0.5628431590751862,"['RB1', 'POLA1', 'TFDP2', 'HDAC1', 'FAF1', 'CHEK1', 'ABL1']",0.7946384474413515,0,0,7
332,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.5682479566048633,1.08322076220885,0.6122335716416207,"['EED', 'MAPK1']",0.7946384474413515,0,0,2
333,Host-pathogen interaction of human coronaviruses - autophagy WP4863,0.5682479566048633,1.08322076220885,0.6122335716416207,"['ATG10', 'ATG5']",0.7946384474413515,0,0,2
334,Immune response to tuberculosis WP4197,0.5682479566048633,1.08322076220885,0.6122335716416207,"['JAK2', 'PIAS1']",0.7946384474413515,0,0,2
335,Kallmann's Syndrome WP5074,0.5682479566048633,1.08322076220885,0.6122335716416207,"['MAPK1', 'GNRH1']",0.7946384474413515,0,0,2
336,Metabolism of Spingolipids in ER and Golgi apparatus WP4142,0.5682479566048633,1.08322076220885,0.6122335716416207,"['GALNT16', 'ST6GALNAC3']",0.7946384474413515,0,0,2
337,Ovarian infertility WP34,0.5682479566048633,1.08322076220885,0.6122335716416207,"['NCOR1', 'ATM']",0.7946384474413515,0,0,2
338,Serotonin Receptor 2 and ELK-SRF/GATA4 signaling WP732,0.5682479566048633,1.08322076220885,0.6122335716416207,"['GNAQ', 'MAPK1']",0.7946384474413515,0,0,2
339,DNA IR-double strand breaks and cellular response via ATM WP3959,0.5683173706384349,1.000697350069735,0.5654693204558452,"['LATS1', 'TRIM28', 'CHEK1', 'ABL1', 'ATM']",0.7946384474413515,0,0,5
340,Canonical and non-canonical Notch signaling WP3845,0.5967725507833221,1.022964509394572,0.5280739463916427,"['CHUK', 'ADAM10']",0.8237505441987987,0,0,2
341,Urea cycle and associated pathways WP4595,0.5967725507833221,1.022964509394572,0.5280739463916427,"['SLC25A12', 'SLC25A13']",0.8237505441987987,0,0,2
342,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.5972135891660325,0.9863708714683646,0.5084549093486551,"['EGLN1', 'PKM', 'ARNT']",0.8237505441987987,0,0,3
343,15q11.2 copy number variation syndrome WP4940,0.6047788805510168,1.150904033379694,0.5787808621108215,['CYFIP1'],0.8237505441987987,0,0,1
344,Cytosine methylation WP3585,0.6047788805510168,1.150904033379694,0.5787808621108215,['TET2'],0.8237505441987987,0,0,1
345,Estrogen Receptor Pathway WP2881,0.6047788805510168,1.150904033379694,0.5787808621108215,['PPARA'],0.8237505441987987,0,0,1
346,Farnesoid X receptor pathway WP2879,0.6047788805510168,1.150904033379694,0.5787808621108215,['PPARGC1A'],0.8237505441987987,0,0,1
347,Thiamine metabolic pathways WP4297,0.6047788805510168,1.150904033379694,0.5787808621108215,['TPK1'],0.8237505441987987,0,0,1
348,Vitamin B12 Disorders WP4271,0.6047788805510168,1.150904033379694,0.5787808621108215,['CUBN'],0.8237505441987987,0,0,1
349,Ciliary landscape WP4352,0.609912249728302,0.9552643731239898,0.4723210934353606,"['RB1', 'POM121', 'CREBBP', 'UBE2H', 'RNGTT', 'IFT140', 'HDAC1', 'IFT172', 'DYNLT3', 'EXOC6B', 'RANBP9', 'ARMC8', 'IFT88', 'APC', 'WDR60', 'EXOC4', 'CEP170', 'CEP290', 'CDR2']",0.8283621959060606,0,0,19
350,Glycerolipids and Glycerophospholipids WP4722,0.6238566496055475,0.9690510200344284,0.4572318636001586,"['CDS1', 'AGPAT4']",0.840079692934743,0,0,2
351,Microglia Pathogen Phagocytosis Pathway WP3937,0.6238566496055475,0.9690510200344284,0.4572318636001586,"['PIK3R3', 'PIK3CB']",0.840079692934743,0,0,2
352,Type II interferon signaling (IFNG) WP619,0.6238566496055475,0.9690510200344284,0.4572318636001586,"['IRF2', 'JAK2']",0.840079692934743,0,0,2
353,Amyotrophic lateral sclerosis (ALS) WP2447,0.6403971720736851,0.9204735376044568,0.4102244165927435,"['PPP3CC', 'ALS2', 'MAP3K5']",0.852817277305967,0,0,3
354,Iron metabolism in placenta WP2007,0.6435254030245284,1.0229485396383866,0.45090934983526987,['TFRC'],0.852817277305967,0,0,1
355,miR-509-3p alteration of YAP1/ECM axis WP3967,0.6435254030245284,1.0229485396383866,0.45090934983526987,['GPC6'],0.852817277305967,0,0,1
356,TCA cycle in senescence WP5050,0.6435254030245284,1.0229485396383866,0.45090934983526987,['PDK1'],0.852817277305967,0,0,1
357,Estrogen signaling pathway WP712,0.6495085171043335,0.9205288796102993,0.3972444156147095,"['CHUK', 'MAPK1']",0.852817277305967,0,0,2
358,SARS-CoV-2 mitochondrial interactions WP5038,0.6495085171043335,0.9205288796102993,0.3972444156147095,"['TBK1', 'TRAF3']",0.852817277305967,0,0,2
359,Signal Transduction of S1P Receptor WP26,0.6495085171043335,0.9205288796102993,0.3972444156147095,"['GNAI3', 'MAPK1']",0.852817277305967,0,0,2
360,Sphingolipid Metabolism (general overview) WP4725,0.6495085171043335,0.9205288796102993,0.3972444156147095,"['CERS6', 'SGMS1']",0.852817277305967,0,0,2
361,Type I collagen synthesis in the context of Osteogenesis imperfecta WP4786,0.6495085171043335,0.9205288796102993,0.3972444156147095,"['P3H2', 'LRP6']",0.852817277305967,0,0,2
362,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.6523835476583414,0.9051514076853557,0.38661064684330315,"['SMAD2', 'GSK3B', 'RALA', 'TBK1', 'APC', 'MAPK1']",0.8542259712432426,0,0,6
363,Apoptosis Modulation and Signaling WP1772,0.6667037396001351,0.8904846588478941,0.36101094052747384,"['PIDD1', 'CRADD', 'CASP6', 'TRAF3', 'CASP2', 'MAP3K5']",0.8553124205219995,0,0,6
364,Exercise-induced Circadian Regulation WP410,0.6723739192740212,0.8764559482329517,0.34790100756256326,"['NCKAP1', 'ZFR', 'CLOCK', 'ETV6']",0.8553124205219995,0,0,4
365,16p11.2 distal deletion syndrome WP4950,0.6737486196023378,0.8766278954170394,0.346178782869212,"['JAK2', 'SDCCAG8']",0.8553124205219995,0,0,2
366,Cannabinoid receptor signaling WP3869,0.6737486196023378,0.8766278954170394,0.346178782869212,"['PRKAR2B', 'MAPK1']",0.8553124205219995,0,0,2
367,Alanine and aspartate metabolism WP106,0.6784756753507843,0.9205841446453408,0.3571007124901401,['PC'],0.8553124205219995,0,0,1
368,Cancer immunotherapy by PD-1 blockade WP4585,0.6784756753507843,0.9205841446453408,0.3571007124901401,['NFAT5'],0.8553124205219995,0,0,1
369,Computational Model of Aerobic Glycolysis WP4629,0.6784756753507843,0.9205841446453408,0.3571007124901401,['PKM'],0.8553124205219995,0,0,1
370,Development and heterogeneity of the ILC family WP3893,0.6784756753507843,0.9205841446453408,0.3571007124901401,['RORA'],0.8553124205219995,0,0,1
371,Homologous recombination WP186,0.6784756753507843,0.9205841446453408,0.3571007124901401,['ATM'],0.8553124205219995,0,0,1
372,Mammary gland development pathway - Embryonic development (Stage 1 of 4) WP2813,0.6784756753507843,0.9205841446453408,0.3571007124901401,['ZEB2'],0.8553124205219995,0,0,1
373,"NAD metabolism, sirtuins and aging WP3630",0.6784756753507843,0.9205841446453408,0.3571007124901401,['FOXO1'],0.8553124205219995,0,0,1
374,ncRNAs involved in STAT3 signaling in hepatocellular carcinoma WP4337,0.6784756753507843,0.9205841446453408,0.3571007124901401,['JAK2'],0.8553124205219995,0,0,1
375,RalA downstream regulated genes WP2290,0.6784756753507843,0.9205841446453408,0.3571007124901401,['RALA'],0.8553124205219995,0,0,1
376,Serotonin and anxiety-related events WP3944,0.6784756753507843,0.9205841446453408,0.3571007124901401,['NLGN1'],0.8553124205219995,0,0,1
377,Monoamine GPCRs WP58,0.6966071584092843,0.8367179097868033,0.302501675670826,"['DRD1', 'HTR4']",0.8735232621322772,0,0,2
378,Photodynamic therapy-induced unfolded protein response WP3613,0.6966071584092843,0.8367179097868033,0.302501675670826,"['EIF2AK3', 'ATF6']",0.8735232621322772,0,0,2
379,Biomarkers for pyrimidine metabolism disorders WP4584,0.7100014070082008,0.8368314578328486,0.28660500618088114,['DPYD'],0.8741316023945122,0,0,1
380,BMP2-WNT4-FOXO1 pathway in primary endometrial stromal cell differentiation WP3876,0.7100014070082008,0.8368314578328486,0.28660500618088114,['FOXO1'],0.8741316023945122,0,0,1
381,Galanin receptor pathway WP4970,0.7100014070082008,0.8368314578328486,0.28660500618088114,['PPARGC1A'],0.8741316023945122,0,0,1
382,Genes targeted by miRNAs in adipocytes WP1992,0.7100014070082008,0.8368314578328486,0.28660500618088114,['PTBP2'],0.8741316023945122,0,0,1
383,Hedgehog Signaling Pathway Netpath WP47,0.7100014070082008,0.8368314578328486,0.28660500618088114,['SUFU'],0.8741316023945122,0,0,1
384,NO metabolism in cystic fibrosis WP4947,0.7100014070082008,0.8368314578328486,0.28660500618088114,['DDAH1'],0.8741316023945122,0,0,1
385,Overview of nanoparticle effects WP3287,0.7100014070082008,0.8368314578328486,0.28660500618088114,['PTK2'],0.8741316023945122,0,0,1
386,Intracellular trafficking proteins involved in CMT neuropathy WP4856,0.7181219679365796,0.8002783576896312,0.26498485070974404,"['KIF1B', 'DNM2']",0.8795602397982912,0,0,2
387,Wnt signaling in kidney disease WP4150,0.7181219679365796,0.8002783576896312,0.26498485070974404,"['INVS', 'LRP6']",0.8795602397982912,0,0,2
388,Nonalcoholic fatty liver disease WP4396,0.7298259669466537,0.8571309879884157,0.2699526972808457,"['VMP1', 'GSK3B', 'PRKAA1', 'ITCH', 'NDUFS4', 'NDUFA2', 'EIF2AK3', 'PIK3R3', 'PIK3CB', 'PPARA', 'MAP3K5']",0.8816614131292804,0,0,11
389,Endothelin Pathways WP2197,0.7383367323778617,0.7668754349338901,0.2326357134471366,"['MAPK1', 'PRKCA']",0.8816614131292804,0,0,2
390,Ethanol effects on histone modifications WP3996,0.7383367323778617,0.7668754349338901,0.2326357134471366,"['KAT2B', 'HDAC1']",0.8816614131292804,0,0,2
391,Trans-sulfuration and one-carbon metabolism WP2525,0.7383367323778617,0.7668754349338901,0.2326357134471366,"['MTHFD1L', 'PSPH']",0.8816614131292804,0,0,2
392,GPR40 Pathway WP3958,0.7384379346251567,0.7670375521557719,0.23257976355967155,['PLCE1'],0.8816614131292804,0,0,1
393,H19 action Rb-E2F1 signaling and CDK-Beta-catenin activity WP3969,0.7384379346251567,0.7670375521557719,0.23257976355967155,['RB1'],0.8816614131292804,0,0,1
394,Omega-3/Omega-6 FA synthesis WP4723,0.7384379346251567,0.7670375521557719,0.23257976355967155,['ACSL4'],0.8816614131292804,0,0,1
395,Omega-9 FA synthesis WP4724,0.7384379346251567,0.7670375521557719,0.23257976355967155,['ACSL4'],0.8816614131292804,0,0,1
396,Phytochemical activity on NRF2 transcriptional activation WP3,0.7384379346251567,0.7670375521557719,0.23257976355967155,['PRKCA'],0.8816614131292804,0,0,1
397,Pyrimidine metabolism and related diseases WP4225,0.7384379346251567,0.7670375521557719,0.23257976355967155,['DPYD'],0.8816614131292804,0,0,1
398,Nuclear Receptors Meta-Pathway WP2882,0.7452095172511268,0.8705655765028334,0.2560245162896416,"['NCOA6', 'TSC22D3', 'ABHD2', 'SLC39A11', 'CUL1', 'ARNT', 'EGFR', 'FOXO1', 'SLC6A6', 'EPB41L4B', 'KAT2B', 'SLC6A9', 'SLC39A6', 'EP300', 'PPARA', 'PPARGC1A', 'EPHA3', 'CPEB4']",0.8875108321031008,0,0,18
399,Metabolic reprogramming in colon cancer WP4290,0.7497995397326267,0.7667130919220055,0.22077456599998407,"['TIGAR', 'PKM', 'PSPH']",0.8907393028402634,0,0,3
400,Cardiac Progenitor Differentiation WP2406,0.7572994777723677,0.7361447459986082,0.2046456573261155,"['GSK3B', 'MEF2C']",0.8920630717581992,0,0,2
401,Neovascularisation processes WP4331,0.7572994777723677,0.7361447459986082,0.2046456573261155,"['SMAD2', 'MAPK1']",0.8920630717581992,0,0,2
402,Differentiation of white and brown adipocyte WP2895,0.7640877787633521,0.7079811704290147,0.19049833622255077,['PPARGC1A'],0.8920630717581992,0,0,1
403,Fatty acid transporters WP5061,0.7640877787633521,0.7079811704290147,0.19049833622255077,['ACSL4'],0.8920630717581992,0,0,1
404,Hypertrophy Model WP516,0.7640877787633521,0.7079811704290147,0.19049833622255077,['ADAM10'],0.8920630717581992,0,0,1
405,PI3K/AKT/mTOR - VitD3 signaling WP4141,0.7640877787633521,0.7079811704290147,0.19049833622255077,['GSK3B'],0.8920630717581992,0,0,1
406,Riboflavin and CoQ disorders WP5037,0.7640877787633521,0.7079811704290147,0.19049833622255077,['PDSS2'],0.8920630717581992,0,0,1
407,TYROBP causal network in microglia WP3945,0.7750613030397516,0.7077779562121942,0.1803511319814608,"['APBB1IP', 'DPYD']",0.9004388667667703,0,0,2
408,Zinc homeostasis WP3529,0.7750613030397516,0.7077779562121942,0.1803511319814608,"['SLC39A6', 'SLC39A11']",0.9004388667667703,0,0,2
409,7q11.23 copy number variation syndrome WP4932,0.7812573360118865,0.7848651042376346,0.19374449087438014,"['RB1', 'CLIP2', 'TSG101', 'HMGA1', 'EIF2AK3', 'ACACA', 'CLASP1']",0.9034966255722108,0,0,7
410,Eicosanoid metabolism via lipooxygenases (LOX) WP4721,0.7872238530829601,0.6573614146632227,0.15726887536813794,['PPARA'],0.9034966255722108,0,0,1
411,Photodynamic therapy-induced NF-kB survival signaling WP3617,0.7872238530829601,0.6573614146632227,0.15726887536813794,['CHUK'],0.9034966255722108,0,0,1
412,PPAR-alpha pathway WP2878,0.7872238530829601,0.6573614146632227,0.15726887536813794,['PPARA'],0.9034966255722108,0,0,1
413,TCA Cycle and Deficiency of Pyruvate Dehydrogenase complex (PDHc) WP2453,0.7872238530829601,0.6573614146632227,0.15726887536813794,['PC'],0.9034966255722108,0,0,1
414,Glycolysis and Gluconeogenesis WP534,0.7916753181592132,0.6815124101136627,0.15920397260306926,"['PKM', 'PC']",0.9042267489336555,0,0,2
415,Tumor suppressor activity of SMARCB1 WP4204,0.7916753181592132,0.6815124101136627,0.15920397260306926,"['RB1', 'EED']",0.9042267489336555,0,0,2
416,"GPCRs, Other WP117",0.7935881692874711,0.7075744589672166,0.16358458548853533,"['GPR176', 'GRM8', 'CELSR3']",0.904232673659282,0,0,3
417,Complement system WP2806,0.8066890426013977,0.6898328690807799,0.1481878344199271,"['PRNP', 'GNAI3', 'PRKCA']",0.9119899496822313,0,0,3
418,Glycosaminoglycan degradation WP4815,0.8080923604779265,0.613490959666203,0.13072199079118504,['ARSB'],0.9119899496822313,0,0,1
419,Mitochondrial LC-Fatty Acid Beta-Oxidation WP368,0.8080923604779265,0.613490959666203,0.13072199079118504,['ACSL4'],0.9119899496822313,0,0,1
420,Simplified Interaction Map Between LOXL4 and Oxidative Stress Pathway WP3670,0.8080923604779265,0.613490959666203,0.13072199079118504,['NRF1'],0.9119899496822313,0,0,1
421,LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258,0.8188468829504938,0.7182705718270572,0.14355224112503492,"['GSK3B', 'APC', 'WIF1', 'MAP3K7', 'LRP6']",0.917836156853469,0,0,5
422,Cytosolic DNA-sensing pathway WP4655,0.8190816336477159,0.6729567226034378,0.13430299959942574,"['TBK1', 'CHUK', 'ATG5']",0.917836156853469,0,0,3
423,Nucleotide Excision Repair WP4753,0.8190816336477159,0.6729567226034378,0.13430299959942574,"['CUL4A', 'ERCC5', 'MNAT1']",0.917836156853469,0,0,3
424,Vitamin A and carotenoid metabolism WP716,0.821677262689301,0.6344155688335373,0.12460403007103144,"['MAPK1', 'RARB']",0.917934197072818,0,0,2
425,Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells WP4301,0.8269154053799437,0.5751043115438108,0.10930023079319769,['MAPK1'],0.917934197072818,0,0,1
426,Nanomaterial induced apoptosis WP2507,0.8269154053799437,0.5751043115438108,0.10930023079319769,['CASP6'],0.917934197072818,0,0,1
427,Regulation of apoptosis by parathyroid hormone-related protein WP3872,0.8269154053799437,0.5751043115438108,0.10930023079319769,['GSK3B'],0.917934197072818,0,0,1
428,Development of ureteric collection system WP5053,0.8351742589691957,0.6132219902574808,0.11045040673907784,"['ITGA8', 'RARB']",0.9206339505846483,0,0,2
429,Mitochondrial CIV Assembly WP4922,0.8351742589691957,0.6132219902574808,0.11045040673907784,"['CMC1', 'COX10']",0.9206339505846483,0,0,2
430,Prostaglandin Synthesis and Regulation WP98,0.8351742589691957,0.6132219902574808,0.11045040673907784,"['ANXA6', 'PPARGC1A']",0.9206339505846483,0,0,2
431,Modulators of TCR signaling and T cell activation WP5072,0.8418435107085689,0.6415592407851266,0.1104515678833545,"['GNA13', 'CHUK', 'RASA2']",0.9238001117728546,0,0,3
432,Nucleotide metabolism WP404,0.843893351049886,0.5412337396711119,0.09186314458054834,['POLA1'],0.9238001117728546,0,0,1
433,Purinergic signaling WP4900,0.843893351049886,0.5412337396711119,0.09186314458054834,['GNAI3'],0.9238001117728546,0,0,1
434,NAD+ biosynthetic pathways WP3645,0.8592069467051421,0.5111265646731572,0.07756114087530823,['TNKS'],0.9362392936511204,0,0,1
435,Triacylglyceride synthesis WP325,0.8592069467051421,0.5111265646731572,0.07756114087530823,['AGPAT4'],0.9362392936511204,0,0,1
436,Vitamin D Receptor Pathway WP2877,0.8662350720338167,0.6806234007908816,0.09773681351793771,"['CLEC16A', 'PRDM1', 'ASAP2', 'TRAK1', 'SLC8A1', 'FOXO1']",0.941732624183553,0,0,6
437,ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336,0.8691924217649191,0.6339060434939324,0.08886776320422003,"['GSK3B', 'APC', 'WIF1', 'LRP6']",0.9427853728068002,0,0,4
438,Striated Muscle Contraction Pathway WP383,0.8730192460026617,0.48418856599077664,0.06575168276433761,['MYOM1'],0.9447742525234285,0,0,1
439,Neural Crest Differentiation WP2064,0.8771337690207089,0.6231146282407134,0.08168769074202803,"['GSK3B', 'HDAC1', 'TCF4', 'SOX5']",0.9470647073253213,0,0,4
440,Mitochondrial complex I assembly model OXPHOS system WP4324,0.8800079709476804,0.5867806554850945,0.07500483455389206,"['NUBPL', 'NDUFS4', 'NDUFA2']",0.9480085868845467,0,0,3
441,Pyrimidine metabolism WP4022,0.8845032691334368,0.6380753138075314,0.0783103894483093,"['PRIM2', 'POLA1', 'PNPT1', 'DPYD', 'ENPP3']",0.949584295272075,0,0,5
442,"Oligodendrocyte specification and differentiation, leading to myelin components for CNS WP4304",0.8854773386292345,0.45994436717663423,0.05594230376849299,['SOX5'],0.949584295272075,0,0,1
443,DNA Repair Pathways Full Network WP4946,0.8921856699314821,0.6801770323782902,0.07759528821609377,"['CUL4A', 'BRIP1', 'FANCM', 'CHEK1', 'ATM', 'ERCC5', 'FANCB', 'MNAT1']",0.9536506724477223,0,0,8
444,1q21.1 copy number variation syndrome WP4905,0.8967139121596196,0.4380091396781244,0.04775105835324358,['PRKAA1'],0.9536506724477223,0,0,1
445,7-oxo-C and 7beta-HC pathways WP5064,0.8967139121596196,0.4380091396781244,0.04775105835324358,['ACOT9'],0.9536506724477223,0,0,1
446,Spinal Cord Injury WP2431,0.8973168774508105,0.6207357985600663,0.06725437472625702,"['RB1', 'PRB1', 'MAPK1', 'PRKCA', 'EGFR']",0.9536506724477223,0,0,5
447,16p11.2 proximal deletion syndrome WP4949,0.9048542259879268,0.5833748133399701,0.058326644862630034,"['MAP2K3', 'KMT2C', 'PTEN', 'BPTF']",0.9573413485262774,0,0,4
448,Fibrin Complement Receptor 3 Signaling Pathway WP4136,0.9068486613677186,0.41806802377038815,0.04087856554835844,['CHUK'],0.9573413485262774,0,0,1
449,Fluoropyrimidine Activity WP1601,0.9068486613677186,0.41806802377038815,0.04087856554835844,['DPYD'],0.9573413485262774,0,0,1
450,Vitamin B12 metabolism WP1533,0.9159895598484988,0.3998609179415855,0.03508792027329839,['CUBN'],0.964842336373752,0,0,1
451,Gastric Cancer Network 2 WP2363,0.9242340067236703,0.38317107093184977,0.030190043074420202,['EGFR'],0.9663271653713923,0,0,1
452,Glycosylation and related congenital defects WP4521,0.9242340067236703,0.38317107093184977,0.030190043074420202,['TUSC3'],0.9663271653713923,0,0,1
453,Cholesterol metabolism (includes both Bloch and Kandutsch-Russell pathways) WP4718,0.9271041460293689,0.4595685455810717,0.03478445476133252,"['ELOVL4', 'ACSL4']",0.9663271653713923,0,0,2
454,Glycerophospholipid Biosynthetic Pathway WP2533,0.9316698619719963,0.3678164116828929,0.026032851098741407,['PIK3CB'],0.9663271653713923,0,0,1
455,One-carbon metabolism WP241,0.9316698619719963,0.3678164116828929,0.026032851098741407,['MTHFD1L'],0.9663271653713923,0,0,1
456,Oxysterols derived from cholesterol WP4545,0.9316698619719963,0.3678164116828929,0.026032851098741407,['ACOT9'],0.9663271653713923,0,0,1
457,Tryptophan metabolism WP465,0.9316698619719963,0.3678164116828929,0.026032851098741407,['CYP2C18'],0.9663271653713923,0,0,1
458,Metapathway biotransformation Phase I and II WP702,0.9354199530611209,0.585915576606138,0.03911554980178345,"['NAA50', 'CYP2U1', 'CYP4V2', 'HS6ST1', 'CYP2C18', 'HS6ST3']",0.9676157879692047,0,0,6
459,"GPCRs, Class A Rhodopsin-like WP455",0.936995035185369,0.5598360376909208,0.03643261519251793,"['RABGAP1', 'RRH', 'DRD1', 'HTR4', 'GPR19']",0.9676157879692047,0,0,5
460,GABA receptor Signaling WP4159,0.9444250516414503,0.34051923968474734,0.01947053176506756,['GABRG3'],0.9710574283688664,0,0,1
461,Peptide GPCRs WP24,0.9444250516414503,0.34051923968474734,0.01947053176506756,['ATP8A1'],0.9710574283688664,0,0,1
462,Differentiation Pathway WP2848,0.9498803649084071,0.3283330021855752,0.016882631466994646,['ALK'],0.9745525821787554,0,0,1
463,PPAR signaling pathway WP3942,0.9562007333434873,0.39944328462073764,0.017890032498866733,"['ACSL4', 'PPARA']",0.9789182453667667,0,0,2
464,Sterol regulatory element-binding proteins (SREBP) signaling WP1982,0.9602767912252113,0.4443121574265433,0.018009620976023207,"['PRKAA1', 'ATF6', 'ACACA']",0.979776225046062,0,0,3
465,NRF2 pathway WP2884,0.9623289180997016,0.5097629009762901,0.019574373424760646,"['SLC6A6', 'SLC6A9', 'SLC39A6', 'SLC39A11', 'EPHA3']",0.979776225046062,0,0,5
466,Fatty acid beta-oxidation WP143,0.963239917450348,0.2964915429135448,0.011104427414311698,['ACSL4'],0.979776225046062,0,0,1
467,Oxidative phosphorylation WP623,0.9661977048088304,0.374902361779785,0.012891693413993531,"['NDUFS4', 'NDUFA2']",0.9806803256517892,0,0,2
468,Hepatitis C and Hepatocellular Carcinoma WP3646,0.9756876298990381,0.2625273196900457,0.00646153113538997,['SOS1'],0.986510627911865,0,0,1
469,Cytoplasmic Ribosomal Proteins WP477,0.9761043976596302,0.44213089290961755,0.01069325993661218,"['RPS6KB1', 'RPS6KA2', 'RPS6', 'RPS20']",0.986510627911865,0,0,4
470,Eukaryotic Transcription Initiation WP405,0.9869255700899099,0.22400692018046744,0.002948077264421625,['MNAT1'],0.9953249366438666,0,0,1
471,Electron Transport Chain (OXPHOS system in mitochondria) WP111,0.9931780569371298,0.3273975328292877,0.0022411405158447467,"['SLC25A27', 'NDUFS4', 'NDUFA2']",0.997229002017577,0,0,3
472,Translation Factors WP107,0.9948456575639957,0.1835605006954103,0.0009485804380389551,['EIF2AK3'],0.997229002017577,0,0,1
473,Selenium Micronutrient Network WP15,0.9953521699265521,0.17994763969565572,0.0008383157386221082,['SELENOP'],0.997229002017577,0,0,1
474,Proteasome Degradation WP183,0.997229002017577,0.16381879594675144,0.00045457165288800025,['PSMD1'],0.997229002017577,0,0,1
